{
  "meta": {
    "title": "88_Pathology_Ini-Cet_2023",
    "url": "https://brainandscalpel.vercel.app/88-pathology-ini-cet-2023-fc4ecbe7.html",
    "scrapedAt": "2025-11-30T12:58:31.263Z"
  },
  "questions": [
    {
      "text": "Which of the following disorders is caused due to abnormal folding of proteins?",
      "choices": [
        {
          "id": 1,
          "text": "Cirrhosis"
        },
        {
          "id": 2,
          "text": "Creutzfeldt-Jakob disease"
        },
        {
          "id": 3,
          "text": "Nephritic syndrome"
        },
        {
          "id": 4,
          "text": "Sickle cell anemia"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p class=\"p1\"><strong>Creutzfeldt-Jakob</strong> disease is caused due to&nbsp;<strong>abnormal folding</strong> of proteins.</p>\n<p class=\"p1\">Creutzfeldt-Jakob disease (CJD)&nbsp;is a prion disease that causes higher cortical function deficits. This infection can be acquired by&nbsp;corneal transplantation, contaminated electroencephalogram (EEG) electrode implantation, dura mater grafts, and&nbsp;contaminated human growth hormone (hGH) preparations.</p>\n<p>Symptoms&nbsp;are almost always&nbsp;rapidly progressive, and the clinical presentation includes the following:</p>\n<ul>\n<li><strong><span data-preserver-spaces=\"true\">Myoclonus</span></strong></li>\n<li><span data-preserver-spaces=\"true\">Higher&nbsp;</span><strong><span data-preserver-spaces=\"true\">cortical deficits</span></strong></li>\n<li><strong><span data-preserver-spaces=\"true\">Psychiatric manifestations -</span></strong><span data-preserver-spaces=\"true\">&nbsp;depression, psychosis, and visual hallucinations</span></li>\n<li><span data-preserver-spaces=\"true\">Profound&nbsp;</span><strong><span data-preserver-spaces=\"true\">dementia -</span></strong><span data-preserver-spaces=\"true\">&nbsp;memory loss, impaired judgment, intellectual decline</span></li>\n<li><span data-preserver-spaces=\"true\">Visual impairment or cerebellar gait and coordination deficits in a few patients</span></li>\n<li><span data-preserver-spaces=\"true\">Nonspecific&nbsp;</span><strong><span data-preserver-spaces=\"true\">prodromal</span></strong><span data-preserver-spaces=\"true\">&nbsp;symptoms - fatigue, sleep disturbance, weight, loss, headache, anxiety, vertigo, malaise, and ill-defined pain&nbsp;</span></li>\n<li><strong><span data-preserver-spaces=\"true\">Extrapyramidal</span></strong><span data-preserver-spaces=\"true\">&nbsp;dysfunction - rigidity, masklike facies, choreoathetoid movements;</span></li>\n<li><strong><span data-preserver-spaces=\"true\">Seizures</span></strong></li>\n<li><span data-preserver-spaces=\"true\">Hypoesthesia</span></li>\n<li><span data-preserver-spaces=\"true\">Supranuclear gaze palsy, optic atrophy</span></li>\n</ul>\n<p>Patients commonly present with <strong>myoclonus</strong>&nbsp;and dementia.&nbsp;EEG shows characteristic&nbsp;<strong>periodic electrical bursts. MRI&nbsp;</strong>shows&nbsp;increased intensity in the basal ganglia and <strong>cortical ribboning&nbsp;</strong>(ribbon-like signal hyperintensity of cerebral cortical gyri). On light microscopy, the pathologic hallmarks of CJD are <strong>spongiform degeneration</strong> and astrocytic gliosis.</p>\n<p>&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1bf3f7af2f2444b49da9f3ba2c5d2137x600x950.JPEG\" alt=\"Explanation Image\"><p>Other options:</p>\n<p>Option C:&nbsp;<strong>Nephritic syndrome</strong>&nbsp;classically presents with tea- or cola-colored urine (hematuria), edema, hypertension, and oliguria.</p>\n<div class=\"ng-star-inserted\">\n<div class=\"table-responsive font-weight-light answer-scroll ng-star-inserted\">\n<p>Conditions which present as glomerulonephritis:</p>\n<ul>\n<li>Postinfectious glomerulonephritis</li>\n<li><strong>IgA nephropathy</strong>&nbsp;(Option D)</li>\n<li>Membranoproliferative glomerulonephritis</li>\n<li>Henoch-Sch&ouml;nlein purpura (HSP) nephritis</li>\n<li>Systemic lupus erythematosus (SLE) nephritis</li>\n<li>Granulomatosis with polyangiitis</li>\n<li><strong>Goodpasture syndrome</strong>&nbsp;(Option C)</li>\n<li>Hemolytic-uremic syndrome (HUS)</li>\n</ul>\n</div>\n</div>\n<div class=\"row ng-star-inserted\">&nbsp;</div>\n<p>Option D:&nbsp;<strong>Sickle cell anemia</strong>&nbsp;is an&nbsp;<strong>autosomal recessive&nbsp;</strong>disorder that occurs due to the&nbsp;<strong>point mutation</strong>&nbsp;in the &beta;-globin gene, which results in the replacement of&nbsp;<strong>glutamate residue with valine</strong>. This causes the production of&nbsp;<strong>sickle-shaped red blood cells</strong>&nbsp;due to the polymerization of&nbsp;<strong>deoxygenated</strong>&nbsp;<strong>hemoglobin (HbS).&nbsp;</strong>Factors that predispose to sickling are infection, dehydration, and acidosis. Clinical features are moderately severe hemolytic anemia with jaundice and&nbsp;<strong>painful bone crisis.&nbsp;</strong>The&nbsp;<strong>aplastic&nbsp;crisis&nbsp;</strong>stems from the infection of red cell progenitors by&nbsp;<strong><em>parvovirus B19</em></strong>, which causes a transient cessation of erythropoiesis and a sudden worsening of the anemia.&nbsp;In children,&nbsp;<strong>splenic sequestration</strong>&nbsp;crises occur which results in&nbsp;<strong>splenomegaly</strong>&nbsp;due to red pulp congestion.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF9241",
      "difficulty": "easy"
    },
    {
      "text": "A 65-year-old male patient with chronic fatigue and lymphadenopathy presents to the outpatient department. His peripheral smear shows the presence of smudge cells. Which of the following additional investigations will you do to arrive at a diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Polymerase chain reaction"
        },
        {
          "id": 2,
          "text": "Fluorescent in situ hybridization"
        },
        {
          "id": 3,
          "text": "Flow cytometry"
        },
        {
          "id": 4,
          "text": "Cytogenetics"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>An elderly patient with chronic fatigue and lymphadenopathy, and a peripheral smear showing the&nbsp;presence of smudge cells suggest a diagnosis of&nbsp;<strong>chronic</strong> <strong>lymphocytic</strong> <strong>leukemia</strong>. Immunophenotyping using<strong> flow cytometry</strong> is the investigation done to arrive at the diagnosis. The classical immunophenotypic feature of CLL is&nbsp;CD 19+, CD20+,&nbsp;<strong>CD 23+, CD5+.</strong></p>\n<p><strong>Chronic Lymphocytic Leukemia (CLL)</strong><strong>&nbsp;</strong>is a peripheral B-cell neoplasm usually affecting adults, more commonly men. Patients are often asymptomatic at diagnosis. When symptomatic, it presents non specifically with easy fatigability, weight loss, and anorexia. <strong>Generalized lymphadenopathy </strong>and<strong> hepatosplenomegaly</strong> are present in most symptomatic patients.&nbsp;</p>\n<p>The chromosomal defects in CLL include:</p>\n<ul>\n<li>Deletion of<strong>&nbsp;13q</strong>&nbsp;(<strong>commonest</strong>&nbsp;and has a good prognosis)</li>\n<li>Deletion of 11q</li>\n<li>Trisomy 12q</li>\n<li>Deletion of&nbsp;<strong>17p</strong>&nbsp;(poor prognosis)</li>\n</ul>\n<p>The peripheral blood smear in cases of chronic lymphocytic leukemia&nbsp;(CLL) contains&nbsp;<strong>small</strong> <strong>round</strong> <strong>lymphocytes</strong>&nbsp;having condensed chromatin and scant cytoplasm. Some of these cells may get disrupted while preparing the smears, producing <strong>smudge</strong> <strong>cells. </strong>An absolute lymphocyte count of &gt;5000/mm<sup>3 </sup>is required for diagnosis. Hypogammaglobulinemia is commonly seen, making the patient susceptible to infections. A few patients may develop&nbsp;<strong>hemolytic anemia or thrombocytopenia</strong>&nbsp;due to autoantibodies made by non-neoplastic B cells.</p>\n<p>On lymph node biopsy: Lymph nodes are composed of small lymphocytes admixed with larger activated lymphocytes. The large lymphocytes contain mitotically active cells and&nbsp;gather in loose aggregates referred to as <strong>proliferation centers.</strong> These proliferation centers are pathognomic to CLL when present.</p>\n<div class=\"page\" title=\"Page 601\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<div class=\"page\" title=\"Page 813\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Expectant management&nbsp;is the treatment of choice for asymptomatic patients with chronic lymphocytic leukemia. The gold standard for therapy is a&nbsp;combination of&nbsp;<strong>fludarabine</strong>,&nbsp;<strong>cyclophosphamide</strong>, and&nbsp;<strong>rituximab.</strong></p>\n<p><strong>Richter&rsquo;s syndrome </strong>is a complication of CLL in which there is a transformation to an aggressive lymphoma, most commonly<strong>&nbsp;diffuse large B-cell lymphoma (DLBCL).</strong></p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n<div class=\"page\" title=\"Page 814\">The image shows small round lymphocytes and smudge cells seen in CLL.</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/3c3c8325438b41cfacc5a99f7184c311x355x512.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Origin of leukemia / lymphoma and their immunophenotypes</h3><table>\n<tbody>\n<tr>\n<td><strong>B cell precursors</strong></td>\n<td><strong>Derived lymphomas/leukemia</strong></td>\n<td><strong>Immunophenotype</strong></td>\n</tr>\n<tr>\n<td>Pro-B cell</td>\n<td>Pro-B cell ALL</td>\n<td>CD34,&nbsp;CD19, CD79a</td>\n</tr>\n<tr>\n<td>Pre-B cell</td>\n<td>Pre-B cell ALL</td>\n<td>CD19, CD79a,&nbsp;CD10, Tdt</td>\n</tr>\n<tr>\n<td>Mature B cell</td>\n<td>CLL/SLL</td>\n<td>\n<p>CD19, CD79a,CD 20, CD21, CD22, surface IgM, CD 23, CD5</p>\n</td>\n</tr>\n<tr>\n<td>Mantle zone</td>\n<td>Mantle zone lymphoma</td>\n<td>CD19, CD79a,CD 20, CD21, CD22, surface IgM, CD5</td>\n</tr>\n<tr>\n<td>Germinal center/Follicular center</td>\n<td>\n<p>Follicular lymphoma</p>\n<p>&nbsp;</p>\n<p>Diffuse large B-cell lymphoma</p>\n<p>Burkitt lymphoma</p>\n</td>\n<td>\n<p>CD 79a, CD 19, CD20, CD21,CD22, CD10, CD 23, Bcl-2</p>\n<p>CD10, Cd23, Bcl-6</p>\n<p>CD19, CD20, CD22, CD79a, CD10, Bcl-6</p>\n</td>\n</tr>\n<tr>\n<td>Memory B cells</td>\n<td>Extranodal marginal zone lymphoma</td>\n<td>CD19, CD79a,CD 20, surface Ig</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>CLL:&nbsp;Chronic lymphocytic leukemia&nbsp;</p>\n<p>SLL:&nbsp;Small lymphocytic lymphoma</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF2206",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following statements is true about blood products?",
      "choices": [
        {
          "id": 1,
          "text": "Platelets is stored between 20°C to 24°C with a shelf life of 5 days."
        },
        {
          "id": 2,
          "text": "Cryoprecipitate is stored at -20°C with a shelf life of 6 months"
        },
        {
          "id": 3,
          "text": "Packed red cells stored with adenine, glucose, mannitol and saline is stored between -5°C to -15°C with a shelf life of 5 weeks"
        },
        {
          "id": 4,
          "text": "Fresh frozen plasma is stored between -5°C to -15°C with a shelf life of 2 years"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The statement that is true about blood products is <strong>platelets</strong>&nbsp;can be stored between <strong>20&deg;C to 24&deg;C</strong> with a shelf life of <strong>5 days.</strong></p>\n<p><strong>Platelet concentrates</strong>&nbsp;can be stored for up to <strong>5 days</strong> at <strong>+20&deg;C to +24&deg;C,</strong> with agitation. It is used in thrombocytopenia, platelet function defects, disseminated intravascular coagulation, during massive blood transfusion to prevent dilutional thrombocytopenia, and in bone marrow failure.&nbsp;Agitation during storage is necessary to maintain their viability and function. This is because platelets are stored at room temperature, where they continue to metabolize glucose and produce lactate. Agitation helps to maintain a uniform distribution of platelets, prevent their clumping together, and facilitate gas exchange.</p>\n<p><strong>Fresh frozen plasma</strong> and <strong>cryoprecipitate</strong> are generally stored at a temperature of&nbsp;<strong>&ndash;30 &deg;C</strong>. They are<strong> thawed</strong> at temperatures between <strong>+30 &deg;C and +37 &deg;C</strong> in the blood bank before issue and transported to the ward at ambient temperature. They must be used immediately and should never be refrozen.</p>\n<p>Whole blood and <strong>packed red cells</strong> are always stored at <strong>+2 &deg;C to +6 &deg;C</strong> and transported between +2 &deg;C and +10 &deg;C. Packed red cells stored with&nbsp;<strong>SAGM</strong> (sodium, adenine, glucose, and mannitol as components) provide a shelf-life of up to&nbsp;<strong>42 days.</strong></p><hr><h3>Related Pearl: Blood components</h3><table>\n<tbody>\n<tr>\n<td><strong>Component</strong></td>\n<td><strong>Volume     (1 unit)</strong></td>\n<td><strong>Content</strong></td>\n<td><strong>Clinical response, increase in </strong></td>\n<td><strong>Storage temperature</strong></td>\n<td><strong>Shelf-life</strong></td>\n</tr>\n<tr>\n<td>Whole blood</td>\n<td>450 ml</td>\n<td>RBCs, platelets, plasma</td>\n<td>Hb and plasma volume</td>\n<td> </td>\n<td> </td>\n</tr>\n<tr>\n<td>Packed red blood cells (PRBCs)</td>\n<td>300-350 ml</td>\n<td>RBCs</td>\n<td>\n<p>Hb by 1 g/dl</p>\n<p>Hematocrit by 3%</p>\n</td>\n<td>\n<p>1° to 6°C</p>\n</td>\n<td>\n<p>ACD/CPD-21 days, CPD-A-35 days, additive-42 days</p>\n</td>\n</tr>\n<tr>\n<td>Random donor platelets (RDP)</td>\n<td>50-70 ml</td>\n<td>Platelets</td>\n<td>platelet count by 5000-10,000/µL</td>\n<td rowspan=\"2\">20 to 24°C</td>\n<td rowspan=\"2\">5 days</td>\n</tr>\n<tr>\n<td>Single donor apheretic platelets (SDP*)</td>\n<td>200-400 ml</td>\n<td>Platelets</td>\n<td>platelet count by 30,000/µL</td>\n</tr>\n<tr>\n<td>Fresh frozen plasma (FFP)</td>\n<td>200-250 ml</td>\n<td>Coagulation factors, protein C, protein S, anti thrombin</td>\n<td>coagulation factors by 2%</td>\n<td>-40 to -50°C</td>\n<td>1 year</td>\n</tr>\n<tr>\n<td>Cryoprecipitate</td>\n<td>10-15 ml</td>\n<td>fibrinogen, factor VIII, VWF</td>\n<td>80 IU Factor VIII</td>\n<td>-30 °C</td>\n<td>1 year</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1b1f01af443f48ec90792074de2e9c37x1280x1063.JPEG\" alt=\"Pearl Image\"><p>*SDP is obtained by collecting multiple units of platelets from a single donor using apheretic technology. </p>\n<p>1 SDP = 6 RDP</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF9248",
      "difficulty": "medium"
    },
    {
      "text": "A patient with lytic lesions on the skull is suspected of a diagnosis of Langerhan cell histiocytosis. Which of the following is a characteristic finding on electron microscopy?",
      "choices": [
        {
          "id": 1,
          "text": "Histiocytes"
        },
        {
          "id": 2,
          "text": "Birbeck granules"
        },
        {
          "id": 3,
          "text": "Eosinophils"
        },
        {
          "id": 4,
          "text": "Giant cells"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The presence of<strong> Birbeck granules</strong>&nbsp;in the cytoplasm is a characteristic finding of Langerhans cell histiocytosis (LCH) on electron microscopy.</p>\n<p>Birbeck granules have a dilated terminal end producing a <strong>tennis racket&ndash;like appearance</strong>. It&nbsp;contains the protein&nbsp;<strong>langerin (CD207). </strong>It is&nbsp;seen on electron microscopy.</p>\n<p>The image below shows&nbsp;<strong>Birbeck granules </strong>on electron microscopy seen in LCH.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/73c07f01368c4588a1294a2217042c96x720x803.JPEG\" alt=\"Explanation Image\"><p>&nbsp;</p>\n<p>Histopathologically,&nbsp;Langerhans cells have a single large nucleus with a characteristic folded or grooved nucleus (<strong>coffee-bean</strong>&nbsp;appearance) with small inconspicuous nucleoli.&nbsp;<strong>Birbeck granules</strong> are seen in the cytoplasm.&nbsp;The tumor cells specifically express <strong>HLA-DR, S-100, and CD1a </strong>and <strong>langerin (CD207) </strong>markers.</p>\n<p>The image below shows histopathological image of Langerhan cells with folded nuclei.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1be94f63d5ae4abba214ad728db1130ex1280x864.JPEG\" alt=\"Explanation Image\"><p>&nbsp;</p>\n<p>Langerhans cell histiocytosis occurs due to the proliferation of a special type of immature dendritic cells, called&nbsp;<strong>Langerhans cells.&nbsp;</strong>Their&nbsp;normal function is to present antigens. The most common mutation is BRAFV600E gain-of-function mutation.</p>\n<p>It is characterized by <strong>single or multiple osteolytic bone lesions </strong>and<strong>&nbsp;</strong>can also infiltrate nearly every organ, like the skin (of the scalp), lungs, liver, spleen, bone marrow, or the central nervous system.&nbsp;</p>\n<p class=\"p1\">LCH can present as the following clinical entities:</p>\n<ul>\n<li class=\"p1\">Multifocal multisystem Langerhans cell histiocytosis <strong>(Letterer-Siwe disease)</strong></li>\n<li class=\"p1\">Unifocal and multifocal unisystem Langerhans cell histiocytosis <strong>(eosinophilic granuloma)-</strong>&nbsp;The combination of bone defects, diabetes insipidus, and exophthalmos is called the <strong>Hand-Sch&uuml;ller-Christian triad.</strong></li>\n<li class=\"p1\">Pulmonary Langerhans cell histiocytosis</li>\n</ul>\n<p>The below image shows lytic lesion of skull seen in LCH.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/7b7ee9fc8f434279b6853e9fde20ca4bx720x828.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Skeletal and Radiological manifestation of  Langerhan’s Cell Histiocytosis</h3><p><strong>Skull:</strong></p>\n<p>Solitary or multiple punched out lytic lesion without sclerotic rim.<br />Double contour or beveled edge appearance may be seen due to asymmetrical involvement of the inner and outer table (hole within a hole sign).<br />Button sequestra representing residual bone.<br />Geographic skull.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/504d808c549645b0bcadbcefbb529c39x720x655.JPEG\" alt=\"Pearl Image\"><p><strong>Spine:</strong></p>\n<p><strong>Vertebra Plana</strong>:it is the most common cause of vertebra plana in children;mostly seen in the thoracic spine.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/0469c0ef21f44d53aefb652fcca8f295x720x845.PNG\" alt=\"Pearl Image\"><p><strong>Mandible:</strong></p>\n<p>Irregular radiolucent areas mostly involving superficial alveolar bone.</p>\n<p><strong>Floating tooth</strong>: loss of lamina dura.</p>\n<p><strong>Long Bones:</strong></p>\n<ul>\n<li>Permeative and aggressive appearing lesions occur</li>\n<li>Mainly involves <strong>diaphysis</strong> or <strong>meta diaphysis</strong></li>\n<li>Endosteal scalloping, Periosteal reaction(in healing phase),cortical thinning,intracortical tunneling and associated soft tissue mass can be seen.</li>\n</ul><hr><h3>Related Pearl: Causes of lytic lesions in the skull</h3><ul>\n<li>Eosinophilic granuloma (geographic lytic lesions in the vault of skull with beveled edges)</li>\n<li>Multiple myeloma (punched out lytic lesion)</li>\n<li>Langerhans Cell Histiocytosis (permeative lesions)</li>\n<li>Hyperparathyroidism (salt and pepper skull)</li>\n<li>Metastasis</li>\n<li>Lymphoma</li>\n<li>Tuberculosis&nbsp;</li>\n<li>Osteomyelitis&nbsp;</li>\n<li>Radiation&nbsp;</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF2222",
      "difficulty": "easy"
    },
    {
      "text": "Identify the mode of inheritance from the pedigree chart given below.",
      "choices": [
        {
          "id": 1,
          "text": "Autosomal dominant"
        },
        {
          "id": 2,
          "text": "Autosomal recessive"
        },
        {
          "id": 3,
          "text": "Pseudodominant inheritance"
        },
        {
          "id": 4,
          "text": "Incomplete penetrance"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The pedigree chart shows an&nbsp;<strong>autosomal dominant</strong> mode of inheritance.</p>\n<div class=\"page\" title=\"Page 153\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Autosomal dominant conditions are manifested in the <strong>heterozygous</strong> state, hence <strong>at least one parent</strong> of an index case is usually affected. In this mode of inheritance, both <strong>males and females</strong> are affected and both can transmit the condition.&nbsp;When an affected person marries an unaffected one, every child has one in two&nbsp;chance of having the disease.</p>\n</div>\n</div>\n</div>\n</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/3a0a20a8c431451c82cef40e00c73cf0x1280x1763.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Inheritance pattern of important diseases</h3><table class=\"t1\">\n<tbody>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>Autosomal dominant</strong></span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>Autosomal recessive</strong></span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>HEAV</strong>y<strong> DOMINANT</strong></span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>ABC DEF GHI</strong></span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>H</strong>: <strong>H</strong>ereditary spherocytosis, <strong>H</strong>ypercholesterolemia,&nbsp;<strong>H</strong>ypertrophic obstructive cardiomyopathy,&nbsp; <strong>H</strong>untington&rsquo;s disease</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">\n<div class=\"p1\"><span><strong>A</strong>: <strong>A</strong>taxia-telangiectasia,&nbsp;<strong>A</strong>lbinism, <strong>A</strong>lkaptonuria,&nbsp;</span></div>\n</div>\n<div class=\"p1\"><span><strong>A</strong>utosomal-recessive polycystic kidney disease</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>E</strong>: <strong>E</strong>hler-Danlos syndrome</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>B</strong>: <strong>B</strong>lood disorders like&nbsp;<strong>b</strong>eta-thalassemia and sickle-cell anemia</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>A</strong>: <strong>A</strong>chondroplasia</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">\n<div class=\"p1\"><span><strong>C</strong>: <strong>C</strong>ystic fibrosis,&nbsp;</span></div>\n</div>\n<div class=\"p1\"><span><strong>C</strong>ongenital adrenal hyperplasia</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>V</strong>: <strong>V</strong>on Willebrand disease, Von Hippel Lindau disease</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>D</strong>: Sensorineural <strong>d</strong>eafness</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>D</strong>: <strong>D</strong>ystrophia myotonica</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">\n<div class=\"p1\"><span><strong>E</strong>: <strong>E</strong>mphysema&nbsp;</span></div>\n</div>\n<div class=\"p1\"><span>(alpha1- antitrypsin deficiency)</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>O</strong>: <strong>O</strong>steogenesis imperfecta,&nbsp;<strong>O</strong>tosclerosis (variable)</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>F</strong>: <strong>F</strong>riedrich ataxia</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>M</strong>: <strong>M</strong>arfans syndrome, Multiple endocrine neoplasias (MEN)</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>G</strong>: <strong>G</strong>aucher&rsquo;s disease, <strong>G</strong>alactosemia, glycogen storage diseases</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>I</strong>: <strong>I</strong>ntermittent porphyria</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>H</strong>: <strong>H</strong>omocystinuria, <strong>H</strong>emochromatosis</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>N</strong>: <strong>N</strong>eurofibromatosis 1 and 2</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>I</strong>: <strong>I</strong>nborn errors of metabolism- Phenylketonuria, lysosomal storage diseases</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\"><span><strong>A</strong>: <strong>A</strong>utosomal-dominant polycystic kidney disease</span></td>\n<td class=\"td1\" valign=\"top\">Other conditions: Wilson's disease, sickle cell anemia, thalassemias, spinal muscular atrophy, Kartagener syndrome,&nbsp;</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\"><span><strong>N</strong>: <strong>N</strong>oonan's syndrome</span></td>\n<td class=\"td1\" valign=\"top\">Mucopolysaccharidoses (except Hunter syndrome)</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\"><span><strong>T</strong>: <strong>T</strong>uberous sclerosis</span></td>\n<td class=\"td1\" valign=\"top\">Sphingolipidoses (except Fabry disease)</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\"><span>Other conditions:<strong>&nbsp;</strong>Familial adenomatous polyposis, Hereditary hemorrhagic telangiectasia, Li-Fraumeni syndrome, Pseudohypoparathyroidism</span></td>\n<td class=\"td1\" valign=\"top\">&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><table class=\"t1\">\n<tbody>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>X-linked recessive</strong></span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>X-linked dominant</strong></span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>Lady Hardinge College Girls Don&rsquo;t Care About Foolish Words</strong></span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>Red Rose </strong>for<strong> All Children</strong></span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">\n<div class=\"p1\"><span>(<strong>L</strong>ady) <strong>L</strong>esch&ndash;Nyhan syndrome,&nbsp;<strong>L</strong>owe syndrome</span></div>\n</div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>R</strong>ed) <strong>R</strong>ett&rsquo;s syndrome</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>H</strong>ardinge) <strong>H</strong>unter's syndrome, <strong>H</strong>emophilia A and B</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>R</strong>ose) <strong>R</strong>ickets</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>C</strong>ollege) <strong>C</strong>hronic granulomatous disease</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div><span>(<strong>A</strong>ll) <strong>A</strong>lport syndrome&nbsp;(common inheritance pattern)</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>G</strong>irls) <strong>G</strong>-6-PD deficiency</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>C</strong>hildren) Type X <strong>C</strong>harcot&ndash;Marie&ndash;Tooth disease</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>D</strong>on&rsquo;t) <strong>D</strong>uchenne muscular dystrophy, <strong>D</strong>iabetes insipidus</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">&nbsp;</div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>C</strong>are) <strong>C</strong>olor blindness</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p2\">&nbsp;</div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">\n<div class=\"p1\"><span>(<strong>A</strong>bout) <strong>A</strong>gammaglobulinemia,&nbsp;<strong>A</strong>lport syndrome, Ocular&nbsp;<strong>a</strong>lbinism</span></div>\n</div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p2\">&nbsp;</div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(Foolish)&nbsp;<strong>F</strong>abry disease</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">&nbsp;</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>W</strong>ords) <strong>W</strong>iskott&ndash;Aldrich syndrome</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">&nbsp;</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">\n<div class=\"p1\"><span>Other conditions: Menke's disease,&nbsp;</span>Ornithine transcarbamylase deficiency</div>\n</div>\n</td>\n<td class=\"td1\" valign=\"top\">&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><span>&nbsp;</span></p><hr><h3>Related Pearl: Pedigree chart for different inheritance patterns</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b04518e36bdd471daf76691dafd74139x1280x2969.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/195c2ef3907e4d8eac2c909799cbef3ex1280x2742.JPEG\" alt=\"Pearl Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/a41c0b0b7401417eb7dd8ba6ac72bb63.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF9239",
      "difficulty": "easy"
    },
    {
      "text": "Match the following disorders with their genetic abnormalities.<div class='question-desc-html'><table>\n<tbody>\n<tr>\n<td>&nbsp;Genetic abnormalities</td>\n<td>&nbsp;Disorders</td>\n</tr>\n<tr>\n<td>&nbsp;1.&nbsp;Trinucleotide repeat</td>\n<td>&nbsp;a.&nbsp;Patau syndrome</td>\n</tr>\n<tr>\n<td>&nbsp;2. Trisomy 18</td>\n<td>&nbsp;b.&nbsp;Huntington chorea</td>\n</tr>\n<tr>\n<td>&nbsp;3.&nbsp;Trisomy 13</td>\n<td>&nbsp;c.&nbsp;Sickle cell anemia</td>\n</tr>\n<tr>\n<td>&nbsp;4.&nbsp;Hb beta chain Glu&rarr;Val</td>\n<td>&nbsp;d.&nbsp;Edward syndrome</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div></div>",
      "choices": [
        {
          "id": 1,
          "text": "1-a, 2-d, 3-b, 4-c"
        },
        {
          "id": 2,
          "text": "1-c, 2-a, 3-b, 4-d"
        },
        {
          "id": 3,
          "text": "1-b, 2-d, 3-a, 4-c"
        },
        {
          "id": 4,
          "text": "1-c, 2-b, 3-a, 4-d"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The correct match is:</p>\n<table>\n<tbody>\n<tr>\n<td>&nbsp;Genetic abnormalities</td>\n<td>&nbsp;Disorders</td>\n</tr>\n<tr>\n<td>&nbsp;1.&nbsp;Trinucleotide repeat</td>\n<td>\n<p>b.&nbsp;Huntington chorea</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;2. Trisomy 18</td>\n<td>\n<p>d.&nbsp;Edward syndrome</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;3.&nbsp;Trisomy 13</td>\n<td>\n<p>a.&nbsp;Patau syndrome</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;4.&nbsp;Hb beta chain Glu&rarr;Val</td>\n<td>\n<p>c.&nbsp;Sickle cell anemia</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Huntington's disease</strong>&nbsp;(HD) is an&nbsp;<strong>autosomal dominant</strong>&nbsp;progressive&nbsp;brain&nbsp;disorder that causes&nbsp;<strong>uncontrolled movements</strong>, emotional problems, and loss of thinking ability. It occurs due to atrophy, with loss of neurons and gliosis in the caudate lobe, putamen, and globus pallidus.&nbsp;There is an abnormal expansion of the&nbsp;<strong>trinucleotide CAG</strong>&nbsp;in the&nbsp;Huntington&nbsp;gene on&nbsp;<strong>chromosome 4</strong>.</p>\n<p><strong>Trisomy</strong> <strong>18 </strong>results in<strong>&nbsp;Edward&rsquo;s syndrome&nbsp;</strong>in which a complete extra copy of chromosome 18 is inherited as a result of meiotic nondisjunction.&nbsp;The clinical features include <strong>micrognathia</strong>, <strong>low-set</strong> <strong>ears</strong>,&nbsp;<strong>prominent</strong> <strong>occiput,</strong> and <strong>rocker bottom feet</strong>. Patients have significant hypertonia including <strong>clenched</strong> <strong>hands</strong> with <strong>overlapping</strong> <strong>fingers</strong>. Cardiac anomalies (ventricular septal defects and patent ductus arteriosus) and gastrointestinal anomalies (Meckel&rsquo;s diverticulum, malrotations) are common. Prenatal ultrasound reveals fetal growth restriction.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/ef7fa7377d60432ca52c7ab71e15b100x452x566.JPEG\" alt=\"Explanation Image\"><p><strong>Trisomy</strong> <strong>13</strong>&nbsp;results in&nbsp;<strong>Patau</strong> <strong>syndrome </strong>which&nbsp;presents with <strong>midline facial clefts</strong>(Cleft lip/palate) and musculoskeletal abnormalities,eg-polydactyly. Phenotypic features include microcephaly, low-set ears, hypertelorism, and a broad nasal bridge.</p>\n<p><strong>Sickle cell anemia</strong> is an&nbsp;<strong>autosomal recessive&nbsp;</strong>disorder that occurs due to the&nbsp;<strong>point mutation</strong>&nbsp;in the &beta;-globin gene, which results in the replacement of <strong>glutamate residue with valine</strong>. This causes the production of&nbsp;<strong>sickle-shaped red blood cells</strong>&nbsp;due to the polymerization of&nbsp;<strong>deoxygenated</strong>&nbsp;<strong>hemoglobin (HbS).&nbsp;</strong>Factors that predispose to sickling are infection, dehydration, and acidosis. Clinical features are moderately severe hemolytic anemia with jaundice and&nbsp;<strong>painful bone crisis. </strong>The <strong>aplastic&nbsp;crisis&nbsp;</strong>stems from the infection of red cell progenitors by&nbsp;<strong><em>parvovirus B19</em></strong>, which causes a transient cessation of erythropoiesis and a sudden worsening of the anemia.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF9229",
      "difficulty": "easy"
    },
    {
      "text": "Most specific indicator of alcohol-induced liver dysfunction is _____",
      "choices": [
        {
          "id": 1,
          "text": "Serum bilirubin"
        },
        {
          "id": 2,
          "text": "GGT"
        },
        {
          "id": 3,
          "text": "SGOT"
        },
        {
          "id": 4,
          "text": "SGPT"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Among the given options, the most specific indicator of alcohol-induced liver dysfunction is <strong>gamma-glutamyl transferase</strong> (GGT).</p>\n<p>GGT is commonly used in patients with&nbsp;<strong>alcoholic liver disease</strong> as a <strong>marker</strong> of excessive alcohol intake. GGT is present in many tissues, including the kidneys, pancreas, and liver. It is mainly&nbsp;derived from the <strong>liver</strong> and this is often used as a marker of <strong>hepatobiliary diseases</strong>. Chronic alcohol consumption leads to the induction of <strong>hepatic microsomal GGT</strong> which leads to a rise in GGT&nbsp; in alcoholics.</p>\n<div class=\"page\" title=\"Page 2659\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Laboratory investigations in patients with alcohol-induced liver dysfunction:</p>\n<ul>\n<li>AST (SGOT) and ALT (SGPT) <strong>elevations</strong> that <strong>do not exceed</strong> 400 IU/L.</li>\n<li>AST/ALT ratio of <strong>&gt;1.5.</strong></li>\n<li>Serum <strong>bilirubin &gt;3 mg/dL</strong>.&nbsp;</li>\n</ul>\n<p>Note that while GGT is a sensitive marker for alcohol-induced liver disease, it is not completely specific to this condition. Other conditions such as biliary obstruction or use of certain medications can also elevate GGT levels.</p>\n</div>\n</div>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF9224",
      "difficulty": "easy"
    },
    {
      "text": "Most common cause of adrenal incidentaloma is_________",
      "choices": [
        {
          "id": 1,
          "text": "Subclinical Cushing's syndrome"
        },
        {
          "id": 2,
          "text": "Aldosterone producing adenoma"
        },
        {
          "id": 3,
          "text": "Pheochromocytoma"
        },
        {
          "id": 4,
          "text": "Non-functioning adenoma"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The most common cause of adrenal incidentaloma is<strong> non-functioning adenoma</strong></p>\n<p>Incidentalomas are evaluated to classify them as:</p>\n<ul>\n<li>Non-functional:&nbsp;<strong>most common</strong>&nbsp;</li>\n<li>Functional: may present with&nbsp;Cushing's syndrome, pheochromocytoma, aldosteronoma, cortisol-producing adenoma,&nbsp;etc.</li>\n<li>Secondary metastasis:<strong>&nbsp;</strong>from<strong>&nbsp;the&nbsp;</strong>breast, lung, and kidneys<strong>&nbsp;</strong>are seen in 2% of the patients.</li>\n</ul>\n<p>For patients without a confirmed diagnosis, it is recommended to conduct specific tests to identify underlying hormonally active tumors. These tests include:</p>\n<p>(a) Performing a <strong>low-dose</strong> (1 mg) <strong>overnight dexamethasone suppression test</strong> to exclude subclinical Cushing's syndrome.</p>\n<p>(b) Collecting a <strong>24-hour urine sample</strong> to measure levels of <strong>catecholamines, metanephrines,</strong> or <strong>VMA</strong>, or measuring plasma metanephrine levels to rule out the presence of a pheochromocytoma.</p>\n<p>(c) In hypertensive patients, conducting tests for <strong>serum electrolytes</strong>, <strong>plasma aldosterone</strong>, and <strong>plasma renin</strong> to exclude the presence of an aldosteronoma.</p>\n<div class=\"page\" title=\"Page 1723\">Management of incidentalomas:</div>\n<ul>\n<li>Non-functional: Tumors with a size &lt;4cm are managed <strong>conservatively</strong>. <strong>MRI surveillance</strong> is done every 3-6 months. For size &gt;4cm, laparoscopic&nbsp;<strong>adrenalectomy</strong>&nbsp;is done.</li>\n<li>\n<p>Functional tumors:&nbsp;<strong>Hormonal assay studies</strong>&nbsp;are done in suspected&nbsp;functional tumors&nbsp;or patients presenting with symptoms. If positive, it should be managed accordingly. If not managed, functional tumors can become&nbsp;malignant&nbsp;and the incidence increases 4-fold if the size of the lesion crosses 4 cm.</p>\n</li>\n<li>\n<p>Secondary metastasis:&nbsp;<strong>Fine-needle aspiration and biopsy </strong>is performed.&nbsp;Tests for pheochromocytoma should always be done before this procedure to avoid precipitating a hypertensive crisis.&nbsp;</p>\n</li>\n</ul><p>Other options:</p>\n<p>Option A: Patients with incidentaloma may present with <strong>subclinical Cushing&rsquo;s syndrome</strong>. This condition is identified by<strong> subtle</strong> indications of <strong>excessive cortisol</strong>, including weight gain, thinning of the skin, facial rounding, diabetes, and high blood pressure. These symptoms are accompanied by the <strong>absence</strong> of the typical <strong>daily variation in cortisol secretion</strong>, autonomous cortisol production, and <strong>insensitivity</strong> to <strong>suppression</strong> by <strong>dexamethasone</strong>. Although the total amount of cortisol produced and the levels of cortisol in 24-hour urine samples may appear normal, other clinical signs and hormone irregularities indicate cortisol excess.</p>\n<p>Option B:&nbsp;<strong>Aldosterone-producing adenomas</strong> originate in the <strong>zona glomerulosa</strong> of the adrenal glands. These tumors are typically 10 to 20 mm in diameter when initially detected, and they have a distinct appearance&mdash;well-defined and exhibiting a <strong>golden yellow color upon slicing</strong>, often referred to as the \"canary tumor.\"</p>\n<p>The most commonly observed mutations occur in the <strong>KCNJ5 gene</strong>, which encodes the <strong>potassium channel</strong>. These mutations are believed to cause an influx of calcium into glomerulosa cells, leading to increased secretion of aldosterone and cellular proliferation. These tumors are more frequently found in females and are associated with <strong>larger tumor sizes</strong> and <strong>higher levels of aldosterone</strong>. However, they are not linked to adrenal hyperplasia.</p>\n<div class=\"page\" title=\"Page 912\">&nbsp;</div>\n<p>Option C: Pheochromocytomas and paragangliomas are <strong>catecholamine-producing tumors</strong>. The dominant clinical feature in&nbsp;<strong>pheochromocytoma</strong>&nbsp;is&nbsp;<strong>hypertension</strong>. Most patients have&nbsp;<strong>paroxysmal episodes</strong>, which are abrupt elevations in blood pressure. They are accompanied by&nbsp;<strong>tachycardia</strong>,&nbsp;<strong>palpitations</strong>,&nbsp;<strong>headache</strong>, and sweating. Lab diagnosis of pheochromocytoma is based on the demonstration of&nbsp;<strong>increased urinary excretion</strong>&nbsp;of&nbsp;<strong>free catecholamines</strong>&nbsp;and their metabolites such as&nbsp;<strong>VMA</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF9392",
      "difficulty": "medium"
    },
    {
      "text": "A patient on long term hemodialysis due to renal failure is likely to develop which type of amyloidosis?",
      "choices": [
        {
          "id": 1,
          "text": "Amyloid light chain (AL)"
        },
        {
          "id": 2,
          "text": "Amyloid A (AA)"
        },
        {
          "id": 3,
          "text": "Amyloid β2 microglobulin (Aβ2M)"
        },
        {
          "id": 4,
          "text": "Amyloid transthyretin (ATTR)"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Patients on <strong>long-term hemodialysis for renal failure</strong> can develop <strong>amyloidosis</strong> as a result of the <strong>deposition of&nbsp;</strong><strong>&beta;2-microglobulin.</strong></p>\n<p><strong>&beta;<sub>2</sub>-microglobulin</strong> is a component of the <strong>MHC class I molecule</strong> and a normal serum protein. In the past, it was retained in the circulation of patients with chronic kidney disease because it <strong>could not be filtered through dialysis membranes</strong>. In these patients, it would get <strong>deposited in the joints</strong>, muscles, <strong>tendons</strong>, and <strong>ligaments</strong>. One of the complications which can occur as a result is <strong>carpal tunnel syndrome</strong>. However, with the advent of new dialysis filters, this complication has become uncommon now.</p><hr><h3>Related Pearl: Biochemical Forms of Amyloid and Associated Clinical Conditions</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Clinicopathological category</strong></p>\n</td>\n<td>\n<p><strong>Biochemical form of amyloid</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Systemic amyloidosis</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Immunocyte dyscrasias with amyloidosis (primary amyloidosis)</p>\n</td>\n<td>\n<p>AL</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Reactive systemic amyloidosis (secondary amyloidosis)</p>\n</td>\n<td>\n<p>AA</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hemodialysis-associated amyloidosis</p>\n</td>\n<td>\n<p>A&beta;2m</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Hereditary amyloidosis</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Familial Mediterranean fever</p>\n</td>\n<td>\n<p>AA</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Familial amyloidotic neuropathies</p>\n</td>\n<td>\n<p>ATTR</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Systemic senile amyloidosis</p>\n</td>\n<td>\n<p>ATTR</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Localised</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Senile cerebral</p>\n</td>\n<td>\n<p>A&beta;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Medullary carcinoma of thyroid</p>\n</td>\n<td>\n<p>A Cal</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Islets of Langerhans</p>\n</td>\n<td>\n<p>AIAPP</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Isolated atrial amyloidosis</p>\n</td>\n<td>\n<p>AANF</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9700",
      "difficulty": "easy"
    },
    {
      "text": "Given below is an electron microscopy image of a cell. Identify the cell.",
      "choices": [
        {
          "id": 1,
          "text": "Target cell"
        },
        {
          "id": 2,
          "text": "Hairy cell"
        },
        {
          "id": 3,
          "text": "Gaucher cell"
        },
        {
          "id": 4,
          "text": "Sickle cell"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given electron microscopic image shows a&nbsp;<strong>hairy cell</strong>.</p>\n<div class=\"page\" title=\"Page 609\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Hairy cell leukemia is so-called because of the&nbsp;appearance of the leukemic cells, which have <strong>fine hair-like projections</strong> that are best recognized under the <strong>phase-contrast microscope.</strong></p>\n</div>\n</div>\n</div>\n</div>\n<p><strong>Hairy cell leukemia</strong> is a distinctive <strong>B cell neoplasm</strong>, that predominantly affects <strong>middle-aged males</strong>. The markers expressed in hairy cell leukemia include the usual&nbsp;<strong>B-cell markers- CD-19 and 20</strong>, and&nbsp;specific markers such as<strong>&nbsp;CD 11c, CD 25, CD103, </strong>and<strong> annexin A1.</strong></p>\n<p>On peripheral blood smear, hairy cells have round or <strong>reniform nuclei</strong> and moderate amounts of <strong>pale blue cytoplasm</strong> with thread or bleb-like extension.&nbsp;In the bone marrow, these cells are usually trapped in a mesh of reticulin fibers and so it is difficult to aspirate and hence termed a <strong>dry tap.&nbsp;</strong></p>\n<p>Patients commonly present with <strong>massive splenomegaly</strong> due to infiltration of the leukemic cells.&nbsp;<strong>Pancytopenia</strong> due to marrow involvement can also be seen. There can be&nbsp;<strong>atypical monocytopenia</strong> due to which these patients experience an<strong> increased </strong>incidence of <strong>atypical mycobacterial infections</strong>. These tumors <strong>respond well to chemotherapy</strong> and BRAF (B-type Raf proto-oncogene) inhibitors and they have an <strong>excellent prognosis</strong>.</p>\n<p>The classic hairy cells can be seen in the slide is shown below:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/d601122fe2154bdd8983552e9ee4e286x640x479.JPEG\" alt=\"Explanation Image\"><p>Other options:</p>\n<p>Option A:&nbsp;Target cells have a centrally located disk of hemoglobin surrounded by an area of pallor. There is an outer rim of hemoglobin adjacent to the cell membrane giving the cell the appearance of a target. Conditions in which target cells appear are <strong>thalassemia</strong>, <strong>hepatic disease</strong> with jaundice, <strong>hemoglobin C</strong> disorders, and&nbsp;<strong>postsplenectomy</strong> state.</p>\n<p>Option C:&nbsp;<strong>Gaucher disease</strong>&nbsp;is a lysosomal storage disorder with a deficiency of&nbsp;<strong>acid-&beta;-glucosidase.</strong>&nbsp;It has an&nbsp;<strong>autosomal recessive</strong>&nbsp;mode of inheritance. It leads to the accumulation of&nbsp;<strong>glucosylceramide</strong>&nbsp;in the reticuloendothelial system.&nbsp;The features of this disease include growth retardation,&nbsp;<strong>hepatosplenomegaly,</strong>&nbsp;thrombocytopenia, anemia, and&nbsp;<strong>Erlenmeyer flask deformity</strong>&nbsp;of the distal femur. Histology shows the presence of&nbsp;<strong>Gaucher cells,&nbsp;</strong>a characteristic&nbsp;<strong>wrinkled-paper</strong>&nbsp;appearance resulting from the presence of intracytoplasmic substrate inclusions. The&nbsp;<strong>intelligence</strong>&nbsp;of the child is&nbsp;<strong>normal.</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/d370b2fcbbfb4b04b29d78113152c966x720x632.PNG\" alt=\"Explanation Image\"><p>Option D:&nbsp;Sickle cell anemia is an&nbsp;<strong>autosomal recessive&nbsp;</strong>disorder that occurs due to the&nbsp;<strong>point mutation</strong>&nbsp;in the &beta;-globin gene, which results in the replacement of glutamate residue with valine. This causes the production of&nbsp;<strong>sickle-shaped red blood cells</strong>&nbsp;due to the polymerization of&nbsp;<strong>deoxygenated</strong>&nbsp;<strong>hemoglobin (HbS).</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/5d897abccb8841ea8c54f6c7969feeb2x720x540.JPEG\" alt=\"Explanation Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/673fcf075eaa4c8180e3344d36a20e8c.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF9246",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following statements is true regarding the immunological abnormality that is seen with the lack of CD40 in B cells is?",
      "choices": [
        {
          "id": 1,
          "text": "Total lack of natural killer cells"
        },
        {
          "id": 2,
          "text": "Lack of CD8 mediated cytotoxicity"
        },
        {
          "id": 3,
          "text": "Decrease in IgG and increase in IgM"
        },
        {
          "id": 4,
          "text": "Inability of neutrophils to fight against infections"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The&nbsp;deficiency of the CD40&nbsp;and its absence in B cells leads to&nbsp;<strong>Hyper IgM syndrome. </strong>A <strong>decrease&nbsp;in IgG and an increase in IgM </strong>is seen in this syndrome.</p>\n<p>The patients most often have&nbsp;<strong>loss-of-function</strong> mutations involving either<strong> CD40</strong> or <strong>activation-induced cytidine deaminase (AID)</strong>,&nbsp;a DNA-editing enzyme expressed in B cells that are required for Ig class switching and affinity maturation.</p>\n<p>The&nbsp;deficiency of the CD40&nbsp;and its absence in B cells&nbsp;<strong>interferes </strong>with<strong> class switching</strong>&nbsp;and the <strong>production</strong> of <strong>memory cells</strong>. The B-cell response to antigens, is unaffected, accounting for the presence of increased IgM antibodies. Hence, the condition is known as Hyper IgM syndrome.</p>\n<div class=\"page\" title=\"Page 253\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<div class=\"page\" title=\"Page 253\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>The serum of the patients has normal or <strong>elevated levels of IgM</strong> but no IgA or IgE and extremely low levels of IgG. Clinical features are&nbsp;<strong>recurrent pyogenic infections</strong>&nbsp;because of low levels of&nbsp;opsonizing IgG antibodies. They are highly&nbsp;susceptible to pneumonia caused by <strong><em>Pneumocystis jirovecii.</em></strong></p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n<p>&nbsp;</p><hr><h3>Related Pearl: Primary immunodeficiency disorders</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Affected component</strong><strong>&nbsp;of the immune system</strong></p>\n</td>\n<td>\n<p><strong>Disorder</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Humoral immunity:&nbsp;</strong>Problems with<strong> B cells</strong>&nbsp;and their <strong>antibody&nbsp;</strong><strong>production</strong></p>\n</td>\n<td>\n<ul>\n<li>Common variable immunodeficiency</li>\n<li>Selective immunoglobulin deficiency, such as IgA deficiency</li>\n<li>Transient hypogammaglobulinemia of infancy</li>\n<li>X-linked agammaglobulinemia</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Cellular immunity:&nbsp;</strong>Problems with<strong> T cells&nbsp;</strong></p>\n</td>\n<td>\n<ul>\n<li>Chronic mucocutaneous candidiasis</li>\n<li>DiGeorge syndrome</li>\n<li>X-linked lymphoproliferative syndrome</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Combined </strong>humoral and cellular immunity:&nbsp;Problems with<strong> B and T cells</strong></p>\n</td>\n<td>\n<ul>\n<li>Ataxia-telangiectasia</li>\n<li>Hyperimmunoglobulinemia M syndrome</li>\n<li>Severe combined immunodeficiency</li>\n<li>Wiskott-Aldrich syndrome</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Phagocytes:&nbsp;</strong>Problems with the<strong> movement or killing&nbsp;</strong></p>\n</td>\n<td>\n<ul>\n<li>Chronic granulomatous disease</li>\n<li>Ch&eacute;diak-Higashi syndrome&nbsp;(rare)</li>\n<li>Tuftsin deficiency</li>\n<li>Cyclic neutropenia</li>\n<li>Leukocyte adhesion defects</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Complement </strong>proteins:<strong>&nbsp;</strong></p>\n<p><strong>Deficiency of complement </strong>proteins</p>\n</td>\n<td>\n<ul>\n<li>Complement component 1 (C1) inhibitor deficiency (hereditary angioedema)</li>\n<li>Terminal complement deficiency (C5-C9): Recurrent Neisseria infections</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF9277",
      "difficulty": "medium"
    },
    {
      "text": "Match the following:<div class='question-desc-html'><table>\n<tbody>\n<tr>\n<td><strong>Condition &nbsp; &nbsp; &nbsp;&nbsp;</strong></td>\n<td><strong>Clinical association</strong></td>\n</tr>\n<tr>\n<td>1. Silicosis</td>\n<td>a. Basal lobes are involved</td>\n</tr>\n<tr>\n<td>2. Mesothelioma &nbsp; &nbsp;</td>\n<td>b. Malignant pleural effusion without mediastinal shift&nbsp;</td>\n</tr>\n<tr>\n<td>3. Caplan syndrome &nbsp; &nbsp;&nbsp;</td>\n<td>c. Initially demonstrated in coal workers</td>\n</tr>\n<tr>\n<td>4. Asbestosis<br />&nbsp;</td>\n<td>d. Crazy pavement&nbsp; &nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div></div>",
      "choices": [
        {
          "id": 1,
          "text": "1-b, 2-d, 3-a, 4-c"
        },
        {
          "id": 2,
          "text": "1-d, 2-b, 3-c, 4-a"
        },
        {
          "id": 3,
          "text": "1-a, 2-b, 3-c, 4-d"
        },
        {
          "id": 4,
          "text": "1-a, 2-b, 3-d, 4-c"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The correctly matched associations of the following conditions are:</p>\n<ul>\n<li>Silicosis: Crazy paving pattern</li>\n<li>Mesothelioma:&nbsp;Malignant pleural effusion without mediastinal shift&nbsp;</li>\n<li>Caplan syndrome:&nbsp;Initially demonstrated in coal workers</li>\n<li>Asbestosis:&nbsp;Basal lobes are involved</li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td>Silicosis</td>\n<td>Asbestosis</td>\n<td>Malignant mesothelioma</td>\n</tr>\n<tr>\n<td>Exposure</td>\n<td>Crystalline <strong>silica</strong></td>\n<td><strong>Asbestos</strong>&nbsp;</td>\n<td>Most specific neoplasm associated with <strong>asbestos</strong> exposure</td>\n</tr>\n<tr>\n<td>\n<p>Radiologic/ Gross findings</p>\n</td>\n<td>\n<p>Simple silicosis - small rounded <strong>opacities</strong> in upper lobes</p>\n<p>Complicated silicosis - Larger opacities &gt; 1cm and <strong>eggshell calcification</strong>&nbsp;of hilar lymph nodes</p>\n<p>Acute silicosis - ground-glass opacities on X-ray and&nbsp;<strong>crazy paving pattern</strong>&nbsp;on HRCT (interlobular septal thickening with background of ground-glass opacity)</p>\n</td>\n<td>\n<p>&nbsp;</p>\n<p>X-ray shows peripheral <strong>reticular opacities</strong> predominantly in the <strong>basal lobes</strong></p>\n<p>HRCT shows subpleural fibrotic lines, irregular opacities, <strong>traction</strong> <strong>bronchiectasis</strong>, and <strong>honeycombing</strong>&nbsp;</p>\n</td>\n<td>Diffuse&nbsp;gelatinous, <strong>greyish-pink&nbsp;lesion</strong> arising either from the visceral or parietal pleura.&nbsp;</td>\n</tr>\n<tr>\n<td>Clinical manifestations</td>\n<td>Increased risk of developing TB and bronchogenic carcinoma&nbsp;</td>\n<td>\n<p>It mainly affects the lower lobes &nbsp;</p>\n<p>PFT shows a&nbsp;<strong data-stringify-type=\"bold\">restrictive pattern</strong>&nbsp;with a decrease in lung volumes and diffusing capacity</p>\n</td>\n<td>\n<p>Strong male predilection 3:1</p>\n<p>Can cause <strong>malignant pleural effusion</strong></p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Caplan's syndrome</strong> also called rheumatoid pneumoconiosis, is a&nbsp;combination of&nbsp;<strong>rheumatoid</strong>&nbsp;<strong>arthritis</strong><strong>&nbsp;and pneumoconiosis.&nbsp;</strong>It manifests as&nbsp;pneumoconiotic nodules&nbsp;along with features of seropositive<strong>&nbsp;</strong>rheumatoid arthritis.&nbsp;Caplan syndrome was first described in <strong>coal miners</strong> and later in patients with silicosis too.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD6935",
      "difficulty": "easy"
    },
    {
      "text": "A 28-year-old female presenting with 36 weeks of gestation, underwent a C-Section for placenta accreta spectrum. During the procedure, there was profuse bleeding and she was transfused blood according to the massive blood transfusion protocol. Which of the following is not seen after a massive blood transfusion?",
      "choices": [
        {
          "id": 1,
          "text": "Hypomagnesemia"
        },
        {
          "id": 2,
          "text": "Hypokalemia"
        },
        {
          "id": 3,
          "text": "Hypocalcemia"
        },
        {
          "id": 4,
          "text": "Hypothermia"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Hyperkalemia</strong>&nbsp;is seen&nbsp;after a <strong>massive blood</strong> transfusion.</p>\n<p><strong>Massive transfusion</strong> is defined as the transfusion of&nbsp;<strong>50%</strong> of the patient&rsquo;s <strong>total blood</strong> volume over <strong>3 hours</strong> or <strong>&gt;5&ndash;10 units</strong> of <strong>RBCs</strong>.</p>\n<p>Complications are:</p>\n<ol>\n<li>Citrate toxicity</li>\n<li><strong>Hypothermia</strong> (Rapid transfusion of blood components at 4&deg;C )</li>\n<li><strong>Hypocalcemia</strong> that presents as circumoral paresthesia.</li>\n<li>Hyperkalemia(RBC leakage during longer storage, and irradiation increases the concentration of potassium in the unit)</li>\n<li>Dilutional coagulopathy</li>\n</ol>\n<p><strong>Prevention</strong> includes the usage of <strong>washed</strong> or <strong>plasma-reduced RBC</strong> components or a storage age of &lt;7&ndash;10 days and the <strong>avoidance</strong> of RBC components stored for <strong>&gt;24 h</strong> after <strong>irradiation. </strong>Treatment includes administration of&nbsp;insulin, glucose, calcium gluconate, and furosemide.</p>\n<div class=\"page\" title=\"Page 936\">Note: As the question was a part of the INI-CET May 2023 exam, the best possible answer has been marked.&nbsp;</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF9279",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following are the true statements about amyloidosis?<div class='question-desc-html'><ol>\n<li><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;True about Amyloidosis is \\nA. It is an extracellular protein\\nB. it is called amyloid because of starch deposition\\nC. Beta pleated sheets are seen on Xray crystallography\\nD. Amyloid L (AL) type is a secondary type of amyloidosis&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:819,&quot;3&quot;:{&quot;1&quot;:0},&quot;4&quot;:{&quot;1&quot;:2,&quot;2&quot;:16777215},&quot;7&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;8&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;11&quot;:4,&quot;12&quot;:0}\">It is an extracellular protein.</span></li>\n<li><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;True about Amyloidosis is \\nA. It is an extracellular protein\\nB. it is called amyloid because of starch deposition\\nC. Beta pleated sheets are seen on Xray crystallography\\nD. Amyloid L (AL) type is a secondary type of amyloidosis&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:819,&quot;3&quot;:{&quot;1&quot;:0},&quot;4&quot;:{&quot;1&quot;:2,&quot;2&quot;:16777215},&quot;7&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;8&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;11&quot;:4,&quot;12&quot;:0}\">It is called amyloid because of starch deposition.</span></li>\n<li><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;True about Amyloidosis is \\nA. It is an extracellular protein\\nB. it is called amyloid because of starch deposition\\nC. Beta pleated sheets are seen on Xray crystallography\\nD. Amyloid L (AL) type is a secondary type of amyloidosis&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:819,&quot;3&quot;:{&quot;1&quot;:0},&quot;4&quot;:{&quot;1&quot;:2,&quot;2&quot;:16777215},&quot;7&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;8&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;11&quot;:4,&quot;12&quot;:0}\">Beta-pleated sheets are seen on X-ray crystallography</span></li>\n<li><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;True about Amyloidosis is \\nA. It is an extracellular protein\\nB. it is called amyloid because of starch deposition\\nC. Beta pleated sheets are seen on Xray crystallography\\nD. Amyloid L (AL) type is a secondary type of amyloidosis&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:819,&quot;3&quot;:{&quot;1&quot;:0},&quot;4&quot;:{&quot;1&quot;:2,&quot;2&quot;:16777215},&quot;7&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;8&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;11&quot;:4,&quot;12&quot;:0}\">AL is a secondary&nbsp;type of amyloidosis.</span></li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "2,3,4"
        },
        {
          "id": 2,
          "text": "1,3,4"
        },
        {
          "id": 3,
          "text": "1,2,3"
        },
        {
          "id": 4,
          "text": "1,2,4"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The true statements about&nbsp;amyloidosis are:</p>\n<ul>\n<li><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;True about Amyloidosis is \\nA. It is an extracellular protein\\nB. it is called amyloid because of starch deposition\\nC. Beta pleated sheets are seen on Xray crystallography\\nD. Amyloid L (AL) type is a secondary type of amyloidosis&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:819,&quot;3&quot;:{&quot;1&quot;:0},&quot;4&quot;:{&quot;1&quot;:2,&quot;2&quot;:16777215},&quot;7&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;8&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;11&quot;:4,&quot;12&quot;:0}\">It is an <strong>extracellular</strong> protein.</span></li>\n<li><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;True about Amyloidosis is \\nA. It is an extracellular protein\\nB. it is called amyloid because of starch deposition\\nC. Beta pleated sheets are seen on Xray crystallography\\nD. Amyloid L (AL) type is a secondary type of amyloidosis&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:819,&quot;3&quot;:{&quot;1&quot;:0},&quot;4&quot;:{&quot;1&quot;:2,&quot;2&quot;:16777215},&quot;7&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;8&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;11&quot;:4,&quot;12&quot;:0}\">It is called amyloid because of <strong>starch</strong> deposition.</span></li>\n<li><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;True about Amyloidosis is \\nA. It is an extracellular protein\\nB. it is called amyloid because of starch deposition\\nC. Beta pleated sheets are seen on Xray crystallography\\nD. Amyloid L (AL) type is a secondary type of amyloidosis&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:819,&quot;3&quot;:{&quot;1&quot;:0},&quot;4&quot;:{&quot;1&quot;:2,&quot;2&quot;:16777215},&quot;7&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;8&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;11&quot;:4,&quot;12&quot;:0}\"><strong>Beta-pleated sheets</strong> are seen on X-ray crystallography.</span></li>\n</ul><p><span data-preserver-spaces=\"true\">Amyloidosis refers to&nbsp;<strong>extracellular </strong>deposits of<strong> fibrillar proteins.&nbsp;</strong></span></p>\n<p><span data-preserver-spaces=\"true\">Abnormal fibrils are produced by the aggregation of <strong>misfolded</strong> proteins. The fibrillar deposits bind a wide variety of</span><span data-preserver-spaces=\"true\">&nbsp;<strong>proteoglycans</strong>&nbsp;and&nbsp;<strong>glycosaminoglycans</strong>, including heparan sulfate and dermatan sulfate, and plasma proteins, notably the serum amyloid P component (SAP). Amyloid appears as an&nbsp;<strong>amorphous, eosinophilic, hyaline, extracellular substance.</strong></span></p>\n<p>The&nbsp;adsorbed proteins contain&nbsp;<strong>abundant charged sugar</strong> groups that give the deposits <strong>staining</strong>&nbsp;characteristics that resemble<strong> starch</strong>. Hence, these deposits were called&nbsp;amyloid.</p>\n<p>It could be classified as systemic, localized, or hereditary amyloidosis.&nbsp;Microscopically, all types of amyloid deposits are made up of continuous,&nbsp;<strong>nonbranching fibrils</strong>. A&nbsp;characteristic <strong>cross-&beta;-pleated sheet</strong> conformation is visualized on <strong>X-ray crystallography</strong> and <strong>infrared spectroscopy.</strong></p>\n<p>The stain used for amyloid deposits is <strong>congo red staining</strong>,<strong>&nbsp;</strong>which&nbsp;imparts<strong> pink to red color</strong> to the amyloid under <strong>ordinary light</strong> and&nbsp;<strong>apple-green birefringence</strong> under <strong>polarised microscopy.</strong></p>\n<p><strong>AL type</strong>(Immunoglobulin light chain amyloidosis) of protein belongs to&nbsp;<strong>primary amyloidosis. </strong>It is seen in<strong>&nbsp;multiple myeloma </strong>and other <strong>monoclonal plasma cell proliferation.</strong></p>\n<p><span data-preserver-spaces=\"true\">The image shows a congo-red stained</span><span data-preserver-spaces=\"true\">&nbsp;biopsy specimen with the following:</span></p>\n<p><span data-preserver-spaces=\"true\"> (A) <strong>F</strong></span><strong><span data-preserver-spaces=\"true\">ocal</span></strong><span data-preserver-spaces=\"true\">&nbsp;</span><strong><span data-preserver-spaces=\"true\">positive staining (orange-red)</span></strong><span data-preserver-spaces=\"true\">&nbsp;of amorphous extracellular material</span></p>\n<p><span data-preserver-spaces=\"true\"> (B) <strong>A</strong></span><strong><span data-preserver-spaces=\"true\">pple-green birefringence </span></strong>under polarized light.</p>\n<p><span data-preserver-spaces=\"true\">The next best step is to determine the type of precursor protein by&nbsp;</span><strong><span data-preserver-spaces=\"true\">immunohistochemistry</span></strong><span data-preserver-spaces=\"true\">, immunoelectron microscopy, or extraction and biochemical analysis using mass spectrometry.</span></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2b2c1e1d1bba4085a97add1af8284d9dx384x207.JPEG\" alt=\"Explanation Image\"><p>As option 2 reads \"It is called amyloid because of starch deposition.\" and not \"It is called amyloid because of starch-<span><strong>like</strong></span>&nbsp;deposition.\", the ideal correct combination would be options 1 and 3. But, since that combination is not available, the second best combination of 1, 2 , and 3 is chosen.</p><hr><h3>Related Pearl: Classification of Amyloidosis</h3><div class=\"page\" title=\"Page 270\">\n<table><colgroup><col /><col /><col /><col /> </colgroup>\n<tbody>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Clinicopathologic Category</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Major Fibril Protein</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Chemically Related Precursor Protein</strong></p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\"3\" rowspan=\"1\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Systemic (Generalized) Amyloidosis:</strong></p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Immunoglobulin light chain amyloidosis (<strong>primary amyloidosis</strong>)</p>\n<p>Seen in Multiple myeloma and other monoclonal plasma cell proliferation</p>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>AL</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Immunoglobulin light chains, chiefly &lambda; type</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Reactive systemic amyloidosis (<strong>secondary amyloidosis</strong>)</p>\n<p>Seen in chronic inflammatory conditions</p>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>AA</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>SAA</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Hemodialysis-associated amyloidosis</p>\n<p>Seen in chronic renal failure</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>A&beta;2m</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>&beta;2-microglobulin</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\"3\" rowspan=\"1\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Hereditary Amyloidosis:</strong></p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Familial Mediterranean fever</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>AA</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>SAA</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Familial amyloidotic neuropathies</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>ATTR</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Mutated transthyretin</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Systemic senile amyloidosis</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>ATTR</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Normal transthyretin</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\"3\" rowspan=\"1\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Localized Amyloidosis:</strong></p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Senile cerebral amyloidosis</p>\n<p>Seen in Alzheimer's disease</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>A&beta;</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>APP</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Endocrine disorders like Type 2 diabetes</p>\n</div>\n</div>\n</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Medullary carcinoma thyroid</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>A Cal</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Calcitonin</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Islets of Langerhans</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>AIAPP</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Islet amyloid peptide</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Isolated atrial amyloidosis</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>AANF</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Atrial natriuretic factor</p>\n</div>\n</div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n</div><hr><h3>Related Pearl: Appearance of Amyloid</h3><table>\n<tbody>\n<tr>\n<td><strong>Methods</strong></td>\n<td><strong>Appearance</strong></td>\n</tr>\n<tr>\n<td>On light microscopy and standard tissue stains&nbsp;(H&amp;E)&nbsp;</td>\n<td>Amorphous eosinophilic extracellular substance&nbsp;</td>\n</tr>\n<tr>\n<td>Congo red stain on ordinary light&nbsp;&nbsp;&nbsp;</td>\n<td>Pink or red&nbsp;colour&nbsp;to tissue deposits&nbsp;</td>\n</tr>\n<tr>\n<td>Congo red stain on polarizing microscopy&nbsp;&nbsp;</td>\n<td>Apple-green birefringence&nbsp;</td>\n</tr>\n<tr>\n<td>Fluorescent stains (thioflavin T and S)&nbsp;&nbsp;&nbsp;</td>\n<td>Yellow&nbsp;colour&nbsp;under UV light&nbsp;</td>\n</tr>\n<tr>\n<td>Electron microscopy&nbsp;</td>\n<td>Nonbranching fibrils of indefinite length and a&nbsp;diameter of approximately 7.5 to 10 nm.&nbsp;</td>\n</tr>\n<tr>\n<td>X-ray crystallography and infrared spectroscopy&nbsp;</td>\n<td>Characteristic cross &beta; pleated sheet conformation&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>H&amp;E: Hematoxylin and eosin &nbsp;</p><hr><h3>Related Pearl: Various stains and their applications in Pathology and Microbiology</h3><table>\n<tbody>\n<tr>\n<td><strong>Staining technique</strong></td>\n<td><strong>Cells/inclusions stained</strong></td>\n<td><strong>Disorders</strong></td>\n</tr>\n<tr>\n<td><strong>H&amp;E</strong></td>\n<td>Most common stain used in routine&nbsp;<strong>histopathology</strong></td>\n<td>Commonly used for all slides</td>\n</tr>\n<tr>\n<td><strong>Papanicolaou stain</strong></td>\n<td>Universal stain for <strong>cytological</strong> preparations</td>\n<td>Cytological studies</td>\n</tr>\n<tr>\n<td><strong>PAS</strong></td>\n<td>Demonstrate&nbsp;<strong>glycogen,&nbsp;mucin,&nbsp;fungi, </strong>macrophages&nbsp;</td>\n<td>Whipple's disease, adenocarcinomas,&nbsp;and glycogen-positive tumors (Ewings sarcoma, renal cell carcinoma)</td>\n</tr>\n<tr>\n<td><strong><strong>PTAH (</strong></strong><strong>Phosphotungstic acid hematoxylin)</strong></td>\n<td>Fibrin</td>\n<td>Gliosis, Ependymomas, Tumours of skeletal muscles, Fibrin deposits</td>\n</tr>\n<tr>\n<td><strong>Alcian blue</strong></td>\n<td>For <strong>acid mucins</strong>: Positive stain for mucins of the intestinal mucosa and negative stain for mucins of gastric mucosa and Brunner's gland</td>\n<td>Barrett's esophagus, Gastric disorders</td>\n</tr>\n<tr>\n<td><strong>Perl's Prussian blue</strong></td>\n<td>Demonstrate&nbsp;<strong>hemosiderin and iron</strong></td>\n<td>Hemochromatosis&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Masson&ndash;Fontana stain</strong></td>\n<td>Demonstrate <strong>melanin</strong></td>\n<td>Nevus and malignant melanoma</td>\n</tr>\n<tr>\n<td><strong>von Kossa method</strong></td>\n<td>Demonstrate&nbsp;<strong>calcium</strong></td>\n<td>Calcification of tissues</td>\n</tr>\n<tr>\n<td><strong>Van Gieson stain</strong></td>\n<td>\n<p>Demonstrate <strong>collagen </strong>in; Differentiate amyloid from collagen</p>\n</td>\n<td>Spindle-cell neoplasm; Delineate extent of fibrosis&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Masson trichrome stain</strong></td>\n<td>Demonstrate <strong>collagen and muscle</strong></td>\n<td>Connective tissue disorders, muscle and fibroblast tumors, liver cirrhosis, neuromuscular diseases&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Reticulin stain</strong></td>\n<td>Demonstrate <strong>reticulin fibers</strong></td>\n<td>Distinguish epithelial from non-epithelial neoplasm, Hodgkin's lymphoma, early cirrhosis of the&nbsp;liver, myelofibrosis</td>\n</tr>\n<tr>\n<td><strong>Verhoeff's method</strong></td>\n<td>Demonstrate <strong>elastic fibers</strong></td>\n<td>Malignant hypertension, arteriovenous malformation aneurysms, Marfan's syndrome, emphysema lung</td>\n</tr>\n<tr>\n<td><strong>Oil red O</strong> <strong>Sudan Black</strong> <strong>Sudan III/IV</strong></td>\n<td>Demonstrate&nbsp;<strong>fat/lipids</strong></td>\n<td>Fatty liver-fat embolism-fibroma vs. thecoma of the&nbsp;ovary-liposarcoma&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Microbiology stains:</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Stain</strong></td>\n<td><strong>&nbsp;Uses</strong></td>\n</tr>\n<tr>\n<td><strong>Ziehl&ndash;Neelsen Stain</strong></td>\n<td>Mycobacteria (all species, including <em>Mycobacterium leprae</em>), <em>Nocardia </em>spp. Cyst of&nbsp;<em>Cryptosporidium parvum</em>, <em>Isospora </em>spp., and&nbsp;<em>Cyclospora</em>&nbsp;spp., Head of sperms</td>\n</tr>\n<tr>\n<td><strong>Masson&rsquo;s Fontana</strong></td>\n<td>Melanin and argentaffin Cells</td>\n</tr>\n<tr>\n<td><strong>Gomori Methenamine Silver</strong></td>\n<td>Fungi</td>\n</tr>\n<tr>\n<td><strong>Luxol Fast Blue (LFB)</strong></td>\n<td>Myelin</td>\n</tr>\n<tr>\n<td><strong>Phosphotungstic Acid-hematoxylin</strong></td>\n<td>Cross striations of skeletal muscle, fibrin</td>\n</tr>\n<tr>\n<td><strong>Toluidine blue</strong></td>\n<td>Mast cells</td>\n</tr>\n<tr>\n<td><strong>Warthin&ndash;Starry</strong></td>\n<td>Helicobacter pylori, spirochetes</td>\n</tr>\n<tr>\n<td><strong>Van Gieson</strong></td>\n<td>Collagen fibres</td>\n</tr>\n<tr>\n<td><strong>Mucicarmine</strong></td>\n<td>Mucin, <em>Cryptococcus</em> capsule</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF9259",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is an anti-apoptotic factor?",
      "choices": [
        {
          "id": 1,
          "text": "PUMA"
        },
        {
          "id": 2,
          "text": "BAD"
        },
        {
          "id": 3,
          "text": "BAK"
        },
        {
          "id": 4,
          "text": "MCL1"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Among the given options<strong>&nbsp;MCL1</strong> is an&nbsp;<strong>anti-apoptotic</strong> factor.</p>\n<p><strong>Anti-apoptotic</strong><em>&nbsp;</em>factors are&nbsp;<strong>BCL2, BCL-XL, and MCL1. </strong>They reside in outer mitochondrial membranes as well as the cytosol and endoplasmic reticulum membranes. By keeping the mitochondrial outer membrane impermeable they prevent leakage of Cytochrome c and other death-inducing proteins into the cytosol.</p>\n<p><strong>Pro-apoptotic </strong>factors are<em>&nbsp;</em><strong>BAX and BAK.&nbsp;</strong>Upon activation, BAX and BAK oligomerize within the outer mitochondrial protein and promote mitochondrial outer membrane permeability which leads to leakage of death-inducing proteins into the cytosol.</p>\n<div class=\"page\" title=\"Page 57\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Regulated <strong>apoptosis initiators</strong> are <strong>BAD, BIM, BID, Puma, and Noxa</strong>. During&nbsp;cellular stress and damage, they get activated and initiate&nbsp;apoptosis.</p>\n</div>\n</div>\n</div>\n</div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF9209",
      "difficulty": "easy"
    },
    {
      "text": "Thymus is designed to recognize the MHC molecules presented to it and distinguish the cells as self and foreign. Which gene is responsible for this?<div class='question-desc-html'><p>MHC- Major histocompatibility complex</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "NOTCH1"
        },
        {
          "id": 2,
          "text": "E2A"
        },
        {
          "id": 3,
          "text": "Rag 1/2"
        },
        {
          "id": 4,
          "text": "AIRE"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The above process is called <strong>central tolerance</strong> and the <strong>AIRE (AutoImmune REgulator)</strong> gene is necessary for this process.</p>\n<p>Central tolerance is a process in which <strong>immature</strong> <strong>self-reactive T and B lymphocyte</strong> clones that <strong>recognize</strong> <strong>self-antigens</strong> during their maturation in the central lymphoid organs (Thymus for T cells, Bone marrow for B cells) are <strong>killed or rendered harmless.</strong></p>\n<p>The removal of <strong>self-reacting T lymphocytes</strong> in the thymus is called <strong>negative selection/ deletion</strong>. For this process, AIRE protein is needed. Mutations in the AIRE gene result in <strong>autoimmune polyendocrinopathy</strong>.</p>\n<p><strong>B-cells</strong> undergo a process called <strong>receptor editing</strong>. When developing B cells encounter a self-antigen, it formulates a change that makes the antigen unrecognizable. Self-reacting B cells can also undergo apoptosis.</p>\n<p>Other options: </p>\n<p>Option A: The NOTCH1 gene is associated with <strong>signal transduction</strong>. Point mutations and translocations of this gene are associated with leukemias, lymphomas, and breast carcinoma. NOTCH1 is the most commonly <strong>affected gene</strong> in <strong>T-cell</strong> <strong>acute lymphoblastic leukemia</strong> (T-ALL).</p>\n<p>Option B: <strong>E2A</strong> also known as <strong>transcription facto</strong>r(TCF3) is an important regulator of <strong>gene expression</strong> in germinal center B cells. It is believed that E2A drives the expression of a set of genes, including <strong>cyclin D,</strong> that collaborate with MYC to enable the rapid growth that characterizes <strong>Burkitt lymphoma</strong>. </p>\n<p>Option C: <strong>RAG1</strong> and <strong>RAG2</strong> are developed by B and T cells that permit the <strong>assembly</strong> of functional antigen receptor genes. Adaptive immunity of B and T cells relies on their ability to diversify their antigen receptor genes.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF9258",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following are the features of necrosis?<div class='question-desc-html'><ol>\n<li><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Which of the following are the features of necrosis?\\nA. Disrupted cell memebrane\\nB. Induces inflammation\\nC. Cell swelling\\nD. Physiological&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:819,&quot;3&quot;:{&quot;1&quot;:0},&quot;4&quot;:{&quot;1&quot;:2,&quot;2&quot;:16777215},&quot;7&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;8&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;11&quot;:4,&quot;12&quot;:0}\">Disrupted cell membrane</span></li>\n<li><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Which of the following are the features of necrosis?\\nA. Disrupted cell memebrane\\nB. Induces inflammation\\nC. Cell swelling\\nD. Physiological&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:819,&quot;3&quot;:{&quot;1&quot;:0},&quot;4&quot;:{&quot;1&quot;:2,&quot;2&quot;:16777215},&quot;7&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;8&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;11&quot;:4,&quot;12&quot;:0}\">Induces inflammation</span></li>\n<li><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Which of the following are the features of necrosis?\\nA. Disrupted cell memebrane\\nB. Induces inflammation\\nC. Cell swelling\\nD. Physiological&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:819,&quot;3&quot;:{&quot;1&quot;:0},&quot;4&quot;:{&quot;1&quot;:2,&quot;2&quot;:16777215},&quot;7&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;8&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;11&quot;:4,&quot;12&quot;:0}\">Swelling of the cell</span></li>\n<li><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Which of the following are the features of necrosis?\\nA. Disrupted cell memebrane\\nB. Induces inflammation\\nC. Cell swelling\\nD. Physiological&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:819,&quot;3&quot;:{&quot;1&quot;:0},&quot;4&quot;:{&quot;1&quot;:2,&quot;2&quot;:16777215},&quot;7&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;8&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;11&quot;:4,&quot;12&quot;:0}\">Physiological</span></li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1,2,4"
        },
        {
          "id": 2,
          "text": "1,2,3"
        },
        {
          "id": 3,
          "text": "2,3,4"
        },
        {
          "id": 4,
          "text": "1,3,4"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The features of necrosis are:</p>\n<ul>\n<li><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Which of the following are the features of necrosis?\\nA. Disrupted cell memebrane\\nB. Induces inflammation\\nC. Cell swelling\\nD. Physiological&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:819,&quot;3&quot;:{&quot;1&quot;:0},&quot;4&quot;:{&quot;1&quot;:2,&quot;2&quot;:16777215},&quot;7&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;8&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;11&quot;:4,&quot;12&quot;:0}\">Disrupted cell membrane</span></li>\n<li><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Which of the following are the features of necrosis?\\nA. Disrupted cell memebrane\\nB. Induces inflammation\\nC. Cell swelling\\nD. Physiological&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:819,&quot;3&quot;:{&quot;1&quot;:0},&quot;4&quot;:{&quot;1&quot;:2,&quot;2&quot;:16777215},&quot;7&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;8&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;11&quot;:4,&quot;12&quot;:0}\">Induces inflammation</span></li>\n<li><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Which of the following are the features of necrosis?\\nA. Disrupted cell memebrane\\nB. Induces inflammation\\nC. Cell swelling\\nD. Physiological&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:819,&quot;3&quot;:{&quot;1&quot;:0},&quot;4&quot;:{&quot;1&quot;:2,&quot;2&quot;:16777215},&quot;7&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;8&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;11&quot;:4,&quot;12&quot;:0}\">Swelling of the cell&nbsp;</span></li>\n</ul>\n<div class=\"page\" title=\"Page 51\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>The characteristics of necrosis are&nbsp;<strong>denaturation</strong> of <strong>cellular proteins</strong>, <strong>leakage</strong> of cellular contents through damaged membranes, <strong>local inflammation</strong>, and enzymatic digestion.</p>\n<p>The causes are&nbsp;<strong>loss of oxygen</strong> supply,&nbsp;exposure to <strong>microbial toxins,</strong> burns, and other forms of chemical and physical injury.</p>\n<p>When the cell <strong>membrane</strong> is <strong>damaged,</strong>&nbsp;lysosomal enzymes enter the cytoplasm and digest the cell. The <strong>contents</strong> from the cell&nbsp;<strong>leak</strong> through the damaged plasma membrane into the extracellular space, where they <strong>elicit inflammation</strong>.</p>\n<p>Morphological changes that occur in necrosis are:</p>\n</div>\n</div>\n</div>\n</div>\n<ul>\n<li>The <strong>cell size</strong> is <strong>increased.</strong></li>\n<li><strong>Cytoplasmic</strong> changes -\n<ul>\n<li>Increased <strong>eosinophilic staining&nbsp;</strong>on H&amp;E specimens</li>\n<li><strong>Moth-eaten </strong>appearance of the cytoplasm&nbsp;- due to vacuolated cytoplasmic organelles formed by enzymatic degradation</li>\n<li><strong>Glassy</strong> and <strong>homogenous </strong>cytoplasm&nbsp;- due to loss of glycogen in the cytoplasm</li>\n</ul>\n</li>\n<li>&nbsp;\n<ul>\n<li><strong>Nuclear </strong>changes -\n<ul>\n<li><strong>Pyknosis -</strong>&nbsp;nucleus first shrinks and becomes more condensed</li>\n<li><strong>Karyorrhexis</strong><strong>&nbsp;-</strong> fragmentation of the pyknotic nucleus</li>\n<li><strong>Karyolysis</strong>&nbsp;- nucleus fades away leaving behind only the cell membrane or empty cells&nbsp;</li>\n</ul>\n</li>\n</ul>\n</li>\n</ul><hr><h3>Related Pearl: Necrosis vs Apoptosis</h3><div class=\"page\" title=\"Page 51\">\n<table><colgroup><col /><col /><col /></colgroup>\n<tbody>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Feature</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Necrosis</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Apoptosis</strong></p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Mechanism</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Enzymatic or ischemic process</p>\n<p>Passive process</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Genetically programmed cell death</p>\n<p>Active process</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>Physiologic or pathologic role</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Invariably <strong>pathologic</strong>&nbsp;</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Both physiologic and pathologic</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Cell size</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Enlarged (swelling)</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Reduced (<strong>shrinkage</strong>)</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Cells affected</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Group of cells</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Single cell death</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Nucleus</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Pyknosis &rarr;karyorrhexis &rarr;karyolysis</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Fragmentation into nucleosome-size fragments</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Plasma membrane</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Disrupted</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Intact</strong>; altered structure</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Cellular contents</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Enzymatic digestion; may leak out of cell</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Intact</strong>; may be released in apoptotic bodies</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Inflammation</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Present</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Absent</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Marker</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>No marker</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Annexin V</strong></p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>PAGE (DNA electrophoresis)</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Smear pattern</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Step-ladder pattern</strong></p>\n</div>\n</div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF9210",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is not essential in the workup of a mosaic Turner syndrome?",
      "choices": [
        {
          "id": 1,
          "text": "Anti-nuclear antibodies"
        },
        {
          "id": 2,
          "text": "Glucose tolerance test"
        },
        {
          "id": 3,
          "text": "Audiometry"
        },
        {
          "id": 4,
          "text": "Echocardiography"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Among the given options, <strong>anti-nuclear antibodies</strong> are <strong>not&nbsp;essential</strong> in the workup of a mosaic Turner syndrome.</p>\n<p>Turner syndrome occurs when females have a <strong>deletion or non-functional X chromosome</strong>. Approximately 50% of individuals with Turner syndrome have a condition called monosomy X (45, XO), where they only have one X chromosome. The remaining 50% have a <strong>mosaic</strong> chromosomal component (<strong>45, X with mosaicism</strong>).</p>\n<p>Mosaic Turner syndrome <strong>does not</strong> stem from<strong> inheritance</strong>. Instead, it is the outcome of a <strong>random occurrence</strong> <strong>during cell division</strong> in the early development of the fetus. This results in a combination of cells in the affected individual's body, where some cells possess the usual two sex chromosomes, while others have only one copy of the X chromosome.</p>\n<p>The clinical features of Turner&rsquo;s syndrome are mentioned in the image below:</p>\n<p>&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/340936f5af594f37aa654a880f002d50x1280x1769.JPEG\" alt=\"Explanation Image\"><p><strong>Prenatal diagnosis</strong> of Turner syndrome can be conducted through procedures like <strong>chorionic villus sampling</strong> or <strong>amniocentesis</strong>. If a prenatal ultrasound reveals fetal hydrops,<strong> cystic hygroma,</strong> or <strong>cardiac defects</strong>, it may raise suspicions of Turner syndrome. However, the <strong>definitive</strong> confirmation of the diagnosis is typically done after birth through <strong>karyotype testing</strong>.</p>\n<p>After receiving a diagnosis of Turner syndrome, it is essential to manage the condition by assessing for any <strong>associated abnormalities</strong> such as cardiac anomalies, renal anomalies, and learning disabilities. Screening should be conducted as part of the initial evaluation, followed by regular periodic screenings.</p>\n<p>During the initial diagnosis, patients should undergo <strong>renal ultrasonography</strong> and <strong>cardiovascular evaluation</strong>. <strong>Echocardiography</strong> is typically performed in infants and children, while MRI is recommended for older girls and women. Regular <strong>monitoring of hearing</strong>, including serial <strong>audiology evaluations</strong>, is recommended throughout life, with an audiology evaluation <strong>every 3 yrs</strong> in <strong>children</strong> and every <strong>five years</strong> in <strong>adults</strong>.</p>\n<p>Several laboratory tests are recommended for screening purposes at specific ages:</p>\n<p>For patients aged <strong>four years and above</strong>, screening involves checking <strong>serum TSH</strong> to detect <strong>autoimmune thyroiditis</strong> and conducting tissue <strong>transglutaminase</strong> testing with total IgA to screen for <strong>celiac</strong> disease.</p>\n<p>For patients aged <strong>ten years and above</strong>, screening includes <strong>fasting blood glucose</strong>, glycated hemoglobin, ALT, AST, serum creatinine, and urinalysis. These tests are performed to screen for conditions such as <strong>diabetes mellitus</strong>, fatty liver, and kidney disease.</p>\n<div>For evaluation of vitamin D deficiency, <strong>serum 25-hydroxyvitamin D</strong> should be measured between <strong>9 to 11 years of age</strong> and every 2 to 3 years thereafter.</div><hr><h3>Related Pearl: Disorders of Sexual Development</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Disorder</strong></p>\n</td>\n<td>\n<p><strong>Complete androgen insensitivity</strong></p>\n</td>\n<td>\n<p><strong>Mullerian agenesis</strong></p>\n</td>\n<td>\n<p><strong>Turner syndrome</strong></p>\n</td>\n<td>\n<p><strong>Complete XY dysgenesis (Swyer syndrome)</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Cause</strong></p>\n</td>\n<td>\n<p>X-linked mutation of androgen receptor</p>\n</td>\n<td>\n<p>Hypoplastic or absent Mullerian ductal system</p>\n<p><strong>Also called Mayer-Rokitansky-K&uuml;ster-Hauser&nbsp;syndrome</strong></p>\n</td>\n<td>\n<p>Complete or partial absence of one X chromosome</p>\n</td>\n<td>\n<p>SRY gene mutation on the Y chromosome</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Reproductive organs</strong></p>\n</td>\n<td>\n<p>Absent uterus and upper vagina, cryptorchid testis</p>\n</td>\n<td>\n<p>Absent or rudimentary uterus and upper vagina, normal ovaries</p>\n</td>\n<td>\n<p>Normal uterus and vagina, streak gonads</p>\n</td>\n<td>\n<p>Normal uterus and vagina, streak gonads</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Breast</strong></p>\n</td>\n<td>\n<p>Yes</p>\n</td>\n<td>\n<p>Yes</p>\n</td>\n<td>\n<p>Variable</p>\n</td>\n<td>\n<p>No</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Axillary/</strong><strong>Pubic hair</strong></p>\n</td>\n<td>\n<p>Minimal to absent</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Minimal to absent</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Karyotype</strong></p>\n</td>\n<td>\n<p>46 XY</p>\n</td>\n<td>\n<p>46 XX</p>\n</td>\n<td>\n<p>45 XO or&nbsp;</p>\n<p>45 X mosaicism</p>\n</td>\n<td>\n<p>46 XY</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p>Note:&nbsp;</p>\n<p>Turner's syndrome have different chromosomal anomalies:</p>\n<ul>\n<li>45 XO which is seen in 40-50% patients&nbsp;</li>\n<li>45 X mosaicism (eg,&nbsp;<span class=\"nowrap\">45,X/46,XX&nbsp;</span>or&nbsp;<span class=\"nowrap\">45,X/47,XXX,</span>&nbsp;or 45,X mosaics with the X chromosome anomalies)</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF9393",
      "difficulty": "medium"
    },
    {
      "text": "Most common genetic cause of hypercoagulability is ______",
      "choices": [
        {
          "id": 1,
          "text": "Factor V Leiden mutation"
        },
        {
          "id": 2,
          "text": "Protein C deficiency"
        },
        {
          "id": 3,
          "text": "Antithrombin III deficiency"
        },
        {
          "id": 4,
          "text": "G20210A prothrombin gene mutation"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The most common genetic cause of hypercoagulability is the&nbsp;<strong>Factor V Leiden mutation.</strong></p>\n<p>Primary (inherited) hypercoagulability is most often caused by mutations in the factor V and prothrombin genes. Factor V Leiden mutation is the most common cause followed by&nbsp;prothrombin G20210A mutation.</p>\n<div class=\"page\" title=\"Page 137\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>The Leiden mutation is inherited in an <strong>autosomal dominant</strong> pattern. The mutation makes factor V <strong>resistant to</strong> <strong>cleavage</strong> and inactivation by protein C. This leads to the inactivation of&nbsp;an important antithrombotic counterregulatory pathway.</p>\n<p><strong>Protein C,</strong> <strong>Protein S,</strong> and <strong>antithrombin III</strong> deficiency are <strong>rare</strong> causes of primary hypercoagulability.</p>\n<p>Other options:</p>\n<p>Option B:&nbsp;<strong>Protein C deficiency</strong>&nbsp;causes thrombosis in teenagers. It may also be induced by&nbsp;liver dysfunction, vitamin K antagonists, renal failure, DIC, and active thrombosis.</p>\n<p>Option C:&nbsp;<strong>Antithrombin III</strong>&nbsp;forms a <strong>complex</strong> with <strong>thrombin</strong> by&nbsp;binding to heparin on endothelial cells. This complex inhibits&nbsp;coagulation.&nbsp;Its deficiency presents as <strong>early-age thrombosis</strong> (less than 50 years old) and it carries the highest risk for thrombotic events among the inherited thrombophilias.</p>\n<p>Option D:&nbsp;The&nbsp;<strong>prothrombin G20210A mutation </strong>results in<strong> increased levels of prothrombin&nbsp;</strong>which<strong>&nbsp;</strong>demonstrates&nbsp;a higher risk for <strong>arterial and venous thrombotic events.</strong></p>\n</div>\n</div>\n</div>\n</div>\n<p>&nbsp;</p><hr><h3>Related Pearl: Hypercoagulable states</h3><p>Primary (Genetic Conditions):</p>\n<ul>\n<li>Mutations in factor V (Most common)</li>\n<li>Antithrombin III deficiency</li>\n<li>Protein C or S deficiency</li>\n<li>Fibrinolysis defects</li>\n<li>Homocysteinemia</li>\n<li>Allelic variations in prothrombin levels</li>\n<li>Mutations in the methyl tetra hydro folate (MTHF) gene</li>\n</ul>\n<p>Secondary (Acquired Conditions):</p>\n<ul>\n<li>Prolonged bed rest or immobilization</li>\n<li>Homocysteinemia</li>\n<li>Tissue damage (Surgery, fracture, burns)</li>\n<li>Cancer</li>\n<li>Myocardial infarction, Prosthetic cardiac valves</li>\n<li>Disseminated intravascular coagulation (DIC)</li>\n<li>Heparin-induced thrombocytopenia</li>\n<li>Antiphospholipid antibody syndrome</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF9275",
      "difficulty": "easy"
    },
    {
      "text": "Identify the histopathological image.",
      "choices": [
        {
          "id": 1,
          "text": "Elastic fibres"
        },
        {
          "id": 2,
          "text": "Routine HPE"
        },
        {
          "id": 3,
          "text": "Amyloidosis"
        },
        {
          "id": 4,
          "text": "Collagen"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><span data-preserver-spaces=\"true\">The given histopathological slide shows&nbsp;<strong>congo red staining </strong>that is used in staining<strong> amyloid.</strong></span></p>\n<p><span data-preserver-spaces=\"true\">Amyloidosis refers to&nbsp;<strong>extracellular </strong>deposits of<strong> fibrillar proteins.&nbsp;</strong></span><span data-preserver-spaces=\"true\">Abnormal fibrils are produced by the aggregation of misfolded proteins. The fibrillar deposits bind a wide variety of</span><span data-preserver-spaces=\"true\">&nbsp;<strong>proteoglycans</strong>&nbsp;and&nbsp;<strong>glycosaminoglycans</strong>, including heparan sulfate and dermatan sulfate, and plasma proteins, notably serum amyloid P component (SAP). Amyloid appears as an&nbsp;<strong>amorphous, eosinophilic, hyaline, extracellular substance.</strong></span></p>\n<p>It could be classified as systemic, localized, and hereditary amyloidosis.&nbsp;Microscopically, all types of amyloid deposits are made up of continuous,&nbsp;<strong>nonbranching fibrils</strong>. A&nbsp;characteristic cross-&beta;-pleated sheet conformation is visualized on X-ray crystallography and infrared spectroscopy.</p>\n<p>The stain used for amyloid deposits is <strong>congo red staining</strong>,<strong>&nbsp;</strong>which&nbsp;imparts<strong> pink to red color</strong> to the amyloid under <strong>ordinary light</strong> and&nbsp;<strong>apple-green birefringence</strong> under <strong>polarised microscopy.</strong></p>\n<p><span data-preserver-spaces=\"true\">The image shows a congo-red stained</span><span data-preserver-spaces=\"true\">&nbsp;biopsy specimen with the following:</span></p>\n<p><span data-preserver-spaces=\"true\"> (A)&nbsp;</span><strong><span data-preserver-spaces=\"true\">focal</span></strong><span data-preserver-spaces=\"true\">&nbsp;</span><strong><span data-preserver-spaces=\"true\">positive staining (orange-red)</span></strong><span data-preserver-spaces=\"true\">&nbsp;of amorphous extracellular material</span></p>\n<p><span data-preserver-spaces=\"true\"> (B)&nbsp;</span><strong><span data-preserver-spaces=\"true\">apple-green birefringence under polarized light</span></strong><span data-preserver-spaces=\"true\">&nbsp;</span></p>\n<p><span data-preserver-spaces=\"true\">The next best step is to determine the type of precursor protein by&nbsp;</span><strong><span data-preserver-spaces=\"true\">immunohistochemistry</span></strong><span data-preserver-spaces=\"true\">, immunoelectron microscopy, or extraction and biochemical analysis using mass spectrometry.</span></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2b2c1e1d1bba4085a97add1af8284d9dx384x207.JPEG\" alt=\"Explanation Image\"><p>Other options:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Connective tissue fibers&nbsp;</strong></td>\n<td><strong>Stain</strong></td>\n<td><strong>Appearance</strong></td>\n</tr>\n<tr>\n<td rowspan=\"5\"><strong>Collagen fibers</strong></td>\n<td>Unaided dye</td>\n<td>White</td>\n</tr>\n<tr>\n<td>Hematoxylin and eosin</td>\n<td>Light pink</td>\n</tr>\n<tr>\n<td>Masson's trichrome</td>\n<td>Blue</td>\n</tr>\n<tr>\n<td>Verhoeff-Van Gieson</td>\n<td>Red</td>\n</tr>\n<tr>\n<td>Silver impregnation</td>\n<td>Brown</td>\n</tr>\n<tr>\n<td><strong>Reticular fibers</strong></td>\n<td>Silver impregnation</td>\n<td>Black</td>\n</tr>\n<tr>\n<td rowspan=\"3\"><strong>Elastic fibers</strong></td>\n<td>Verhoeff-Van Gieson</td>\n<td>Black</td>\n</tr>\n<tr>\n<td>Aldehyde fuchsin</td>\n<td>Purple</td>\n</tr>\n<tr>\n<td>Orcein</td>\n<td>Purplish brown</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/0942054fa38a4703b54b0e0393ae4852x1279x1403.JPEG\" alt=\"Explanation Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/54de18b7cf5a44758f08dbab6f165ab2x1279x1345.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Classification of Amyloidosis</h3><div class=\"page\" title=\"Page 270\">\n<table><colgroup><col /><col /><col /><col /> </colgroup>\n<tbody>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Clinicopathologic Category</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Major Fibril Protein</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Chemically Related Precursor Protein</strong></p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\"3\" rowspan=\"1\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Systemic (Generalized) Amyloidosis:</strong></p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Immunoglobulin light chain amyloidosis (<strong>primary amyloidosis</strong>)</p>\n<p>Seen in Multiple myeloma and other monoclonal plasma cell proliferation</p>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>AL</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Immunoglobulin light chains, chiefly &lambda; type</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Reactive systemic amyloidosis (<strong>secondary amyloidosis</strong>)</p>\n<p>Seen in chronic inflammatory conditions</p>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>AA</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>SAA</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Hemodialysis-associated amyloidosis</p>\n<p>Seen in chronic renal failure</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>A&beta;2m</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>&beta;2-microglobulin</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\"3\" rowspan=\"1\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Hereditary Amyloidosis:</strong></p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Familial Mediterranean fever</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>AA</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>SAA</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Familial amyloidotic neuropathies</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>ATTR</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Mutated transthyretin</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Systemic senile amyloidosis</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>ATTR</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Normal transthyretin</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\"3\" rowspan=\"1\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Localized Amyloidosis:</strong></p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Senile cerebral amyloidosis</p>\n<p>Seen in Alzheimer's disease</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>A&beta;</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>APP</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Endocrine disorders like Type 2 diabetes</p>\n</div>\n</div>\n</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Medullary carcinoma thyroid</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>A Cal</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Calcitonin</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Islets of Langerhans</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>AIAPP</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Islet amyloid peptide</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Isolated atrial amyloidosis</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>AANF</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Atrial natriuretic factor</p>\n</div>\n</div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n</div><hr><h3>Related Pearl: Appearance of Amyloid</h3><table>\n<tbody>\n<tr>\n<td><strong>Methods</strong></td>\n<td><strong>Appearance</strong></td>\n</tr>\n<tr>\n<td>On light microscopy and standard tissue stains&nbsp;(H&amp;E)&nbsp;</td>\n<td>Amorphous eosinophilic extracellular substance&nbsp;</td>\n</tr>\n<tr>\n<td>Congo red stain on ordinary light&nbsp;&nbsp;&nbsp;</td>\n<td>Pink or red&nbsp;colour&nbsp;to tissue deposits&nbsp;</td>\n</tr>\n<tr>\n<td>Congo red stain on polarizing microscopy&nbsp;&nbsp;</td>\n<td>Apple-green birefringence&nbsp;</td>\n</tr>\n<tr>\n<td>Fluorescent stains (thioflavin T and S)&nbsp;&nbsp;&nbsp;</td>\n<td>Yellow&nbsp;colour&nbsp;under UV light&nbsp;</td>\n</tr>\n<tr>\n<td>Electron microscopy&nbsp;</td>\n<td>Nonbranching fibrils of indefinite length and a&nbsp;diameter of approximately 7.5 to 10 nm.&nbsp;</td>\n</tr>\n<tr>\n<td>X-ray crystallography and infrared spectroscopy&nbsp;</td>\n<td>Characteristic cross &beta; pleated sheet conformation&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>H&amp;E: Hematoxylin and eosin &nbsp;</p><hr><h3>Related Pearl: Various stains and their applications in Pathology and Microbiology</h3><table>\n<tbody>\n<tr>\n<td><strong>Staining technique</strong></td>\n<td><strong>Cells/inclusions stained</strong></td>\n<td><strong>Disorders</strong></td>\n</tr>\n<tr>\n<td><strong>H&amp;E</strong></td>\n<td>Most common stain used in routine&nbsp;<strong>histopathology</strong></td>\n<td>Commonly used for all slides</td>\n</tr>\n<tr>\n<td><strong>Papanicolaou stain</strong></td>\n<td>Universal stain for <strong>cytological</strong> preparations</td>\n<td>Cytological studies</td>\n</tr>\n<tr>\n<td><strong>PAS</strong></td>\n<td>Demonstrate&nbsp;<strong>glycogen,&nbsp;mucin,&nbsp;fungi, </strong>macrophages&nbsp;</td>\n<td>Whipple's disease, adenocarcinomas,&nbsp;and glycogen-positive tumors (Ewings sarcoma, renal cell carcinoma)</td>\n</tr>\n<tr>\n<td><strong><strong>PTAH (</strong></strong><strong>Phosphotungstic acid hematoxylin)</strong></td>\n<td>Fibrin</td>\n<td>Gliosis, Ependymomas, Tumours of skeletal muscles, Fibrin deposits</td>\n</tr>\n<tr>\n<td><strong>Alcian blue</strong></td>\n<td>For <strong>acid mucins</strong>: Positive stain for mucins of the intestinal mucosa and negative stain for mucins of gastric mucosa and Brunner's gland</td>\n<td>Barrett's esophagus, Gastric disorders</td>\n</tr>\n<tr>\n<td><strong>Perl's Prussian blue</strong></td>\n<td>Demonstrate&nbsp;<strong>hemosiderin and iron</strong></td>\n<td>Hemochromatosis&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Masson&ndash;Fontana stain</strong></td>\n<td>Demonstrate <strong>melanin</strong></td>\n<td>Nevus and malignant melanoma</td>\n</tr>\n<tr>\n<td><strong>von Kossa method</strong></td>\n<td>Demonstrate&nbsp;<strong>calcium</strong></td>\n<td>Calcification of tissues</td>\n</tr>\n<tr>\n<td><strong>Van Gieson stain</strong></td>\n<td>\n<p>Demonstrate <strong>collagen </strong>in; Differentiate amyloid from collagen</p>\n</td>\n<td>Spindle-cell neoplasm; Delineate extent of fibrosis&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Masson trichrome stain</strong></td>\n<td>Demonstrate <strong>collagen and muscle</strong></td>\n<td>Connective tissue disorders, muscle and fibroblast tumors, liver cirrhosis, neuromuscular diseases&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Reticulin stain</strong></td>\n<td>Demonstrate <strong>reticulin fibers</strong></td>\n<td>Distinguish epithelial from non-epithelial neoplasm, Hodgkin's lymphoma, early cirrhosis of the&nbsp;liver, myelofibrosis</td>\n</tr>\n<tr>\n<td><strong>Verhoeff's method</strong></td>\n<td>Demonstrate <strong>elastic fibers</strong></td>\n<td>Malignant hypertension, arteriovenous malformation aneurysms, Marfan's syndrome, emphysema lung</td>\n</tr>\n<tr>\n<td><strong>Oil red O</strong> <strong>Sudan Black</strong> <strong>Sudan III/IV</strong></td>\n<td>Demonstrate&nbsp;<strong>fat/lipids</strong></td>\n<td>Fatty liver-fat embolism-fibroma vs. thecoma of the&nbsp;ovary-liposarcoma&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Microbiology stains:</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Stain</strong></td>\n<td><strong>&nbsp;Uses</strong></td>\n</tr>\n<tr>\n<td><strong>Ziehl&ndash;Neelsen Stain</strong></td>\n<td>Mycobacteria (all species, including <em>Mycobacterium leprae</em>), <em>Nocardia </em>spp. Cyst of&nbsp;<em>Cryptosporidium parvum</em>, <em>Isospora </em>spp., and&nbsp;<em>Cyclospora</em>&nbsp;spp., Head of sperms</td>\n</tr>\n<tr>\n<td><strong>Masson&rsquo;s Fontana</strong></td>\n<td>Melanin and argentaffin Cells</td>\n</tr>\n<tr>\n<td><strong>Gomori Methenamine Silver</strong></td>\n<td>Fungi</td>\n</tr>\n<tr>\n<td><strong>Luxol Fast Blue (LFB)</strong></td>\n<td>Myelin</td>\n</tr>\n<tr>\n<td><strong>Phosphotungstic Acid-hematoxylin</strong></td>\n<td>Cross striations of skeletal muscle, fibrin</td>\n</tr>\n<tr>\n<td><strong>Toluidine blue</strong></td>\n<td>Mast cells</td>\n</tr>\n<tr>\n<td><strong>Warthin&ndash;Starry</strong></td>\n<td>Helicobacter pylori, spirochetes</td>\n</tr>\n<tr>\n<td><strong>Van Gieson</strong></td>\n<td>Collagen fibres</td>\n</tr>\n<tr>\n<td><strong>Mucicarmine</strong></td>\n<td>Mucin, <em>Cryptococcus</em> capsule</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/9974d3317aca48ffaad0f8831609b2c8.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF9278",
      "difficulty": "medium"
    },
    {
      "text": "BRCA 1 gene is associated with______<div class='question-desc-html'><ol>\n<li><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;BRCA 1 gene is associated with\\nA. Repair of ds DNA break\\nB. Risk of development of ovarian cancer\\nC.Tumor suppressor gene\\nD. Mutation seen in subset of Fanconi anemia&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:819,&quot;3&quot;:{&quot;1&quot;:0},&quot;4&quot;:{&quot;1&quot;:2,&quot;2&quot;:16777215},&quot;7&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;8&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;11&quot;:4,&quot;12&quot;:0}\">Repair of ds DNA break</span></li>\n<li><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;BRCA 1 gene is associated with\\nA. Repair of ds DNA break\\nB. Risk of development of ovarian cancer\\nC.Tumor suppressor gene\\nD. Mutation seen in subset of Fanconi anemia&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:819,&quot;3&quot;:{&quot;1&quot;:0},&quot;4&quot;:{&quot;1&quot;:2,&quot;2&quot;:16777215},&quot;7&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;8&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;11&quot;:4,&quot;12&quot;:0}\">Risk of development of ovarian cancer</span></li>\n<li><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;BRCA 1 gene is associated with\\nA. Repair of ds DNA break\\nB. Risk of development of ovarian cancer\\nC.Tumor suppressor gene\\nD. Mutation seen in subset of Fanconi anemia&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:819,&quot;3&quot;:{&quot;1&quot;:0},&quot;4&quot;:{&quot;1&quot;:2,&quot;2&quot;:16777215},&quot;7&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;8&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;11&quot;:4,&quot;12&quot;:0}\">Tumor suppressor gene</span></li>\n<li><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;BRCA 1 gene is associated with\\nA. Repair of ds DNA break\\nB. Risk of development of ovarian cancer\\nC.Tumor suppressor gene\\nD. Mutation seen in subset of Fanconi anemia&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:819,&quot;3&quot;:{&quot;1&quot;:0},&quot;4&quot;:{&quot;1&quot;:2,&quot;2&quot;:16777215},&quot;7&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;8&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;11&quot;:4,&quot;12&quot;:0}\">Mutation is seen in the subset of Fanconi anemia</span></li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1,2,3"
        },
        {
          "id": 2,
          "text": "1,3,4"
        },
        {
          "id": 3,
          "text": "2,3,4"
        },
        {
          "id": 4,
          "text": "1,2,4"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The statements associated with the <strong>BRCA1 gene</strong> are:</p>\n<ul>\n<li><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;BRCA 1 gene is associated with\\nA. Repair of ds DNA break\\nB. Risk of development of ovarian cancer\\nC.Tumor suppressor gene\\nD. Mutation seen in subset of Fanconi anemia&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:819,&quot;3&quot;:{&quot;1&quot;:0},&quot;4&quot;:{&quot;1&quot;:2,&quot;2&quot;:16777215},&quot;7&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;8&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;11&quot;:4,&quot;12&quot;:0}\">Repair of ds DNA break</span></li>\n<li><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;BRCA 1 gene is associated with\\nA. Repair of ds DNA break\\nB. Risk of development of ovarian cancer\\nC.Tumor suppressor gene\\nD. Mutation seen in subset of Fanconi anemia&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:819,&quot;3&quot;:{&quot;1&quot;:0},&quot;4&quot;:{&quot;1&quot;:2,&quot;2&quot;:16777215},&quot;7&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;8&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;11&quot;:4,&quot;12&quot;:0}\">Risk of development of ovarian cancer</span></li>\n<li><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;BRCA 1 gene is associated with\\nA. Repair of ds DNA break\\nB. Risk of development of ovarian cancer\\nC.Tumor suppressor gene\\nD. Mutation seen in subset of Fanconi anemia&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:819,&quot;3&quot;:{&quot;1&quot;:0},&quot;4&quot;:{&quot;1&quot;:2,&quot;2&quot;:16777215},&quot;7&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;8&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;11&quot;:4,&quot;12&quot;:0}\">Tumor suppressor gene</span></li>\n</ul>\n<p><strong>BRCA1 </strong>and<strong> BRCA2 </strong>are<strong> </strong>t<span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;BRCA 1 gene is associated with\\nA. Repair of ds DNA break\\nB. Risk of development of ovarian cancer\\nC.Tumor suppressor gene\\nD. Mutation seen in subset of Fanconi anemia&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:819,&quot;3&quot;:{&quot;1&quot;:0},&quot;4&quot;:{&quot;1&quot;:2,&quot;2&quot;:16777215},&quot;7&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;8&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;11&quot;:4,&quot;12&quot;:0}\">umor suppressor genes. Mutations of these genes are associated with an increased risk of <strong>breast cancer</strong> in females. They play an important role in the <strong>repair</strong> of </span><strong>double-stranded breaks</strong> in DNA.</p>\n<p><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;BRCA 1 gene is associated with\\nA. Repair of ds DNA break\\nB. Risk of development of ovarian cancer\\nC.Tumor suppressor gene\\nD. Mutation seen in subset of Fanconi anemia&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:819,&quot;3&quot;:{&quot;1&quot;:0},&quot;4&quot;:{&quot;1&quot;:2,&quot;2&quot;:16777215},&quot;7&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;8&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;11&quot;:4,&quot;12&quot;:0}\">In addition to breast cancer, women with <strong>BRCA1 mutations</strong> have a higher risk of developing epithelial <strong>ovarian</strong> cancers, and men have a slightly higher risk of <strong>prostate</strong> cancer. BRCA2 is associated with </span>cancers of the ovary, prostate, pancreas, bile ducts, stomach, melanocytes, and B lymphocytes.</p>\n<p>Few <strong>germline BRCA2</strong> mutations can cause <strong>Fanconi anemia</strong>. Both BRCA proteins and Fanconi proteins function together in a DNA damage response network linked to homologous recombination repair. Defects in this pathway can lead to the <strong>activation</strong> of a <strong>nonhomologous end-joining pathway</strong> that can result in telomere shortening.</p>\n<div class=\"page\" title=\"Page 323\"> </div><hr><h3>Related Pearl: Comparison between BRCA 1 and BRCA 2:</h3><div class=\"panel-body ng-scope\">\n<p>Both <em>BRCA1</em> and <em>BRCA2</em> are <strong>tumor suppressor genes.</strong></p>\n<p>Carcinoma breast <strong>occurs at an earlier age</strong> and is <strong>bilateral and multicentric in </strong>inherited forms compared to sporadic cases.</p>\n<table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>BRCA 1</strong></td>\n<td><strong>BRCA 2</strong></td>\n</tr>\n<tr>\n<td>Location</td>\n<td>Long arm of <strong>chromosome 17</strong>&nbsp;</td>\n<td>Long arm of <strong>chromosome 13</strong></td>\n</tr>\n<tr>\n<td>Differentiation</td>\n<td>Poorly differentiated</td>\n<td>Well-differentiated</td>\n</tr>\n<tr>\n<td>Hormone receptor status</td>\n<td>ER/PR- Negative, Her-2 negative &ndash; triple negative</td>\n<td>ER/PR- Positive</td>\n</tr>\n<tr>\n<td>Associated Cancers</td>\n<td>Breast, ovarian, colon, and prostate (lesser extent), Pancreas (lesser extent)&nbsp; cancers</td>\n<td>Breast, ovarian, colon, prostate, pancreas, gall bladder, stomach cancers, and melanoma</td>\n</tr>\n<tr>\n<td>Male breast carcinoma</td>\n<td>Low risk</td>\n<td><strong>Increased risk</strong></td>\n</tr>\n<tr>\n<td>Fanconi&rsquo;s anemia</td>\n<td>Not associated</td>\n<td>Associated</td>\n</tr>\n<tr>\n<td>Medullary carcinoma</td>\n<td>Associated</td>\n<td>Not associated</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF9280",
      "difficulty": "medium"
    },
    {
      "text": "A phlebotomist has been asked to take samples from a patient for multiple tests. Which of the following order of blood collection for testing will not contaminate the sample based on the additives present in the collecting tubes?",
      "choices": [
        {
          "id": 1,
          "text": "Light blue -> Red-> Lavender-> Grey"
        },
        {
          "id": 2,
          "text": "Light blue -> Lavender-> Red-> Grey"
        },
        {
          "id": 3,
          "text": "Grey-> Red->Light blue -> Lavender"
        },
        {
          "id": 4,
          "text": "Red-> Lavender-> Grey->Light blue"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The correct color sequence of the blood collection tube is <strong>light blue-&gt; red-&gt; lavender-&gt; grey.</strong></p>\n<p>The Clinical &amp; Laboratory Standards Institute (CLSI) has recommended a color sequence for multiple collections of venous and/or arterial blood samples in a single patient.</p>\n<p>Yellow, pink, and blue→ light Blue→ red→ green→ lavender→ grey.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2a0cd1a9fda3452ba2126e2a5302272cx710x3391.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Anticoagulants in Vacutainers and their Uses</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/208956b39e504182a7fab1330d186f3cx1280x2189.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF9274",
      "difficulty": "medium"
    },
    {
      "text": "A transbronchial biopsy of a patient with fever, cough and weight loss shows the findings of the biopsy below. Which of the following chemical mediators are involved in its pathogenesis?",
      "choices": [
        {
          "id": 1,
          "text": "IFN gamma"
        },
        {
          "id": 2,
          "text": "Bradykinin"
        },
        {
          "id": 3,
          "text": "C5a"
        },
        {
          "id": 4,
          "text": "Prostaglandin"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong class=\"animating\">Interferon gamma (IFN-γ) </strong>i<span class=\"animating\">s a <strong>pro-inflammatory cytokine</strong> that is involved in the formation of granulomas.</span><span class=\"animating\"> It <strong>activates macrophages</strong> to differentiate into <strong>epithelioid cells</strong> and <strong>multinucleated giant cells</strong>,</span><span class=\"animating\"> which are the main components of granulomas.</span></p>\n<p data-sourcepos=\"12:1-12:170\"><span class=\"animating\">IFN-γ is the most important chemical mediator involved in the pathogenesis of granulomas.</span><span class=\"animating\"> It is produced by <strong>T helper 1 (Th1) cells</strong> and other immune cells in response to a variety of stimuli,</span><span class=\"animating\"> including infections,</span><span class=\"animating\"> autoimmune diseases,</span><span class=\"animating\"> and foreign bodies.</span></p>\n<p><strong>Interferon-gamma-induced changes</strong> in the macrophages:</p>\n<ol>\n<li><strong>Augmented ability</strong> of the macrophages to <strong>phagocytose</strong> and kill micro-organisms.</li>\n<li><strong>Increased</strong> expression of<strong> class 2 MHC molecules</strong> to enhance antigen presentation.</li>\n<li>Increased secretion in presence of <strong>tumor necrosis factor, interleukin-1,</strong> and other inflammatory chemokines.</li>\n<li><strong>Amplification</strong> of the Th1 response by producing more <strong>interleukin-12.</strong></li>\n</ol>\n<p data-sourcepos=\"14:1-14:454\"><span class=\"animating\"><strong>Granulomas</strong> are characteristic of a number of diseases,</span><span class=\"animating\"> including <strong>tuberculosis,</strong></span><strong><span class=\"animating\"> sarcoidosis,</span></strong><span class=\"animating\"><strong> and Crohn's disease</strong>.</span><span class=\"animating\"> In these diseases,</span><span class=\"animating\"> IFN-γ plays a central role in the formation of granulomas,</span><span class=\"animating\"> which help to <strong>contain and eliminate</strong> the offending agent.</span><span class=\"animating\"> However,</span><span class=\"animating\"> granulomas can also be formed in response to non-harmful stimuli,</span><span class=\"animating\"> such as foreign bodies or allergens.</span><span class=\"animating\"> In these cases,</span><span class=\"animating\"> granulomas can be harmful and can lead to tissue damage and organ dysfunction.</span></p>\n<p><strong class=\"animating\">B. Bradykinin:</strong><span class=\"animating\"> Bradykinin is a vasodilator that is involved in the inflammatory response.</span><span class=\"animating\"> It is not directly involved in the formation of granulomas.</span></p>\n<p><strong class=\"animating\">C. Complement C5a:</strong><span class=\"animating\"> Complement C5a is a chemoattractant that attracts neutrophils and other inflammatory cells to the site of infection or injury.</span><span class=\"animating\"> It is not directly involved in the formation of granulomas.</span></p>\n<p><strong class=\"animating\">D. Prostaglandin:</strong><span class=\"animating\"> Prostaglandins are a group of signaling molecules that are involved in a variety of physiological processes,</span><span class=\"animating\"> including inflammation.</span><span class=\"animating\"> Prostaglandins can promote or inhibit the formation of granulomas,</span><span class=\"animating\"> depending on the context.</span></p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/db9335dac1d049e88c02736e6e86292e.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG1039",
      "difficulty": "easy"
    },
    {
      "text": "A patient with rapidly progressive renal failure (RPRF) presents with crescentic glomerulonephritis which is found to be pauci-immune. Which of the following antibodies are involved in this condition?",
      "choices": [
        {
          "id": 1,
          "text": "ANA"
        },
        {
          "id": 2,
          "text": "ANCA"
        },
        {
          "id": 3,
          "text": "Anti-GBM"
        },
        {
          "id": 4,
          "text": "Anti-PLA2R"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p data-sourcepos=\"5:1-5:21\"><strong>ANCA - antineutrophil cytoplasmic antibody </strong>is<strong> </strong>the <strong>most common </strong>antibody associated with<strong> pauci-immune crescentic</strong> glomerulonephritis.</p>\n<p data-sourcepos=\"5:1-5:21\">There are two main types of ANCA: myeloperoxidase <strong>(MPO)-ANCA</strong> and proteinase-3 <strong>(PR3)-ANCA. </strong>MPO-ANCA is more strongly associated with renal-limited vasculitis, while PR3-ANCA is more strongly associated with systemic vasculitis.</p>\n<p><strong><span data-preserver-spaces=\"true\">Rapidly progressive glomerulonephritis (RPGN) </span></strong><span data-preserver-spaces=\"true\">is a clinical entity with features of nephritic syndrome and rapid loss of renal function. It is a syndrome associated with severe glomerular injury with necrosis and the formation of crescents, but it does not denote a specific etiologic form of glomerulonephritis.</span></p>\n<p><span data-preserver-spaces=\"true\">In most cases, </span><strong><span data-preserver-spaces=\"true\">RPGN is immune-mediated</span></strong><span data-preserver-spaces=\"true\">. Circulating anti-neutrophil cytoplasmic antibodies (ANCAs) are detected in the pauci-immune type of RPGN. Serum analyses for anti-GBM antibodies, antinuclear antibodies, and ANCAs are helpful in the diagnosis of specific subtypes</span></p>\n<p><span data-preserver-spaces=\"true\">Based on immunologic findings, RPGN is classified as:</span></p>\n<p><strong><span data-preserver-spaces=\"true\">Anti-GBM antibody-mediated disease</span></strong><span data-preserver-spaces=\"true\"> (Type I) is characterized by linear GBM deposits of IgG and C3 on immunofluorescence and includes </span><strong><span data-preserver-spaces=\"true\">renal limited disease</span></strong><span data-preserver-spaces=\"true\"> and </span><strong><span data-preserver-spaces=\"true\">Goodpasture's</span></strong><span data-preserver-spaces=\"true\"> </span><strong><span data-preserver-spaces=\"true\">disease</span></strong><span data-preserver-spaces=\"true\">. Here, the antibodies are produced against a peptide present in the noncollagenous domain of the α3 chain of collagen IV of the GBM. This serves as the antigen which is common to the alveoli and the glomerulus.</span></p>\n<p><strong><span data-preserver-spaces=\"true\">Immune complex deposition</span></strong><span data-preserver-spaces=\"true\"> (Type II) is characterized by granular deposits of antibodies and complement on immunofluorescence and can be a complication of any of the immune complex nephritides which include:</span></p>\n<ul>\n<li><span data-preserver-spaces=\"true\">Postinfectious glomerulonephritis</span></li>\n<li><span data-preserver-spaces=\"true\">Lupus nephritis</span></li>\n<li><span data-preserver-spaces=\"true\">IgA nephropathy</span></li>\n<li><span data-preserver-spaces=\"true\">Henoch-Schönlein purpura</span></li>\n</ul>\n<p><strong><span data-preserver-spaces=\"true\">Pauci-immune</span></strong><span data-preserver-spaces=\"true\"> (Type III) exhibits no characteristic immunoglobulin or complement deposits on immunofluorescence. It includes</span></p>\n<ul>\n<li><span data-preserver-spaces=\"true\">ANCA-associated</span></li>\n<li><span data-preserver-spaces=\"true\">Granulomatosis with polyangiitis</span></li>\n<li><span data-preserver-spaces=\"true\">Microscopic polyangiitis</span></li>\n</ul>\n<p data-sourcepos=\"11:1-11:33\">Other options:</p>\n<p data-sourcepos=\"11:1-11:33\">Option A:<strong> ANA - antinuclear antibody: </strong>ANA is a non-specific antibody seen in most autoimmune disorders; including lupus, rheumatoid arthritis, and scleroderma. ANA is not typically associated with pauci-immune crescentic glomerulonephritis.</p>\n<p data-sourcepos=\"16:1-16:60\">Option C: <strong>Anti-GBM - anti-glomerular basement membrane antibody:</strong> directed against the glomerular basement membrane. Anti-GBM is associated with anti-GBM disease/Goodpasture syndrome, a type of rapidly progressive glomerulonephritis that is characterized by <strong>linear deposits</strong> of IgG along the BM.</p>\n<p data-sourcepos=\"21:1-21:59\">Option D:<strong> Anti-PLA2R - anti-phospholipase A2 receptor antibody: </strong>Anti-PLA2R is an antibody that is directed against the phospholipase A2 receptor; <span class=\"animating\">associated with <strong>membranous nephropathy</strong>, where</span><span class=\"animating\"> thickening of the glomerular basement membrane is characteristic.</span></p><hr><h3>Related Pearl: Types of Rapidly Progressive Glomerulonephritis</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Type I (Anti-GBM Antibody)</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Renal limited</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Goodpasture syndrome</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Immunofluorescence:&nbsp;</p>\n<p>Linear GBM deposits of IgG and C3</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Type II (Immune Complex)</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Idiopathic</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Post-streptococcal glomerulonephritis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Membranoproliferative glomerulonephritis</p>\n</td>\n</tr>\n<tr>\n<td>Crescentic glomerulonephritis</td>\n</tr>\n<tr>\n<td>\n<p>Lupus nephritis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Henoch&ndash;Sch&ouml;nlein purpura</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>IgA nephropathy</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Others:&nbsp;Cryoglobulinemia,&nbsp;Bacterial endocarditis, sepsis,&nbsp;acute pancreatitis/advanced liver disease</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Immunofluorescence:&nbsp;Granular pattern of staining</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Type III (Pauci-Immune)</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>ANCA-associated</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Idiopathic</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Granulomatosis with polyangiitis (formerly Wegener granulomatosis)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Microscopic polyangiitis</p>\n</td>\n</tr>\n<tr>\n<td>Immunofluorescence:&nbsp;No immunoglobulin or complement deposits</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p>Image: Crescentic glomerulonephritis (PAS stain) with the crescent-shaped mass of proliferating parietal epithelial cells and leukocytes internal to Bowman capsule.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/bc82f88b949d4f94bfd60049ae235674x800x533.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1da539adb07347789a398d272db0f337x1279x1112.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG1085",
      "difficulty": "medium"
    },
    {
      "text": "Sickle cells have  _________:",
      "choices": [
        {
          "id": 1,
          "text": "High mechanical fragility and high osmotic fragility"
        },
        {
          "id": 2,
          "text": "High mechanical fragility and low osmotic fragility"
        },
        {
          "id": 3,
          "text": "Low mechanical fragility and high osmotic fragility"
        },
        {
          "id": 4,
          "text": "Low mechanical fragility and low osmotic fragility"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Sickle cells have <strong>high mechanical fragility and low osmotic fragility</strong>.</p>\n<p>When subjected to<strong> mechanical stress</strong>, such as <strong>shearing forces. trauma, turbulence.</strong> Sickle cells have high mechanical fragility because they are <strong>more rigid and less deformable</strong> than normal red blood cells. This makes them more likely to break apart when subjected to mechanical stress.</p>\n<p>The higher concentration of hemoglobin in sickle cells makes them less likely to break apart when subjected to osmotic stress; such as <strong>changes in the concentration of salt - de/overhydration, CKD, etc. This is because the sickle cell hemoglobin (HbS) protein is more resistant to swelling in hypotonic solutions.</strong></p>\n<table>\n<tbody>\n<tr>\n<td>Disease</td>\n<td>Mechanical fragility</td>\n<td>Osmotic fragility</td>\n</tr>\n<tr>\n<td>Sickle cell anemia</td>\n<td>High</td>\n<td>Low</td>\n</tr>\n<tr>\n<td>Thalassemia</td>\n<td>High</td>\n<td>Low</td>\n</tr>\n<tr>\n<td>Malaria</td>\n<td>High</td>\n<td>High</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Conditions that can cause increased<strong> mechanical fragility</strong> of red blood cells:</p>\n<ul>\n<li aria-level=\"1\">Sickle cell anemia</li>\n<li aria-level=\"1\">Thalassemia: Thalassemia can cause RBCs to become smaller and less flexible. This can make them more mechanically fragile.</li>\n<li aria-level=\"1\">Red blood cell membrane disorders</li>\n<li aria-level=\"1\">G6PD deficiency</li>\n<li aria-level=\"1\">Autoimmune hemolytic anemia</li>\n<li aria-level=\"1\">Malaria</li>\n</ul>\n<p>Conditions that can cause increased <strong>osmotic fragility</strong> of red blood cells:</p>\n<ul>\n<li aria-level=\"1\">Hereditary spherocytosis</li>\n<li aria-level=\"1\">Elliptocytosis</li>\n<li aria-level=\"1\">Ovalocytosis</li>\n<li aria-level=\"1\">Autoimmune hemolytic anemia</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG1022",
      "difficulty": "medium"
    },
    {
      "text": "B cells express IgM and IgD antibodies at the same time due to which phenomenon?",
      "choices": [
        {
          "id": 1,
          "text": "Somatic hypermutation"
        },
        {
          "id": 2,
          "text": "Alternative RNA splicing"
        },
        {
          "id": 3,
          "text": "Affinity maturation"
        },
        {
          "id": 4,
          "text": "Allelic exclusion"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>B cells</strong> express <strong>IgM </strong>and<strong> IgD</strong> antibodies at the same time due to <strong>alternative RNA splicing</strong>.</p>\n<p><strong>Alternative RNA splicing </strong>is the process by which<strong> </strong><strong>different proteins </strong>are produced from the<strong> same RNA transcript </strong>by <strong>splicing </strong>it in different ways.</p>\n<p><strong>Mature </strong>circulating <strong>B </strong><strong>cells</strong> initially express <strong>IgM </strong>and<strong> IgD</strong> <strong>antibodies </strong>on their surfaces before they are stimulated to produce specific antibodies. The heavy chains in <strong>IgM</strong> and <strong>IgD </strong>are <strong>mu </strong>(μ) and <strong>delta </strong>(δ), respectively. The <strong>mu </strong>and <strong>delta genes</strong> for these heavy chains are located <strong>proximal to the VDJ</strong> encoding regions (i.e., <strong>variable, diversity,</strong> and <strong>joining regions)</strong> of the heavy chain locus. A <strong>primary RNA transcript</strong> of this entire region is produced, which then undergoes alternative RNA processing, enabling the production of both transmembrane IgM and IgD on B cells.</p>\n<p>Other options:</p>\n<p class=\"p1\">Options A and C:<strong> Somatic hypermutation</strong> is a cellular response by which the immune system adapts to the new foreign elements that confront it. They do so by adding nucleotides in V gene regions of heavy and light chains, resulting in a<strong> better fit</strong> of antigen with the antibodies. This hence <strong>increases</strong> the <strong>affinity</strong> of antibodies to antigens. Due to this, the subset of plasma cells with these improved hypervariable regions are more strongly selected by the antigen and therefore constitute a larger part of the population of antibody-producing cells. This process is called <strong>affinity maturation.</strong></p>\n<p class=\"p1\">Option D:<strong> Allelic exclusion</strong> is the process by which a cell <strong>expresses one </strong>of the<strong> two alleles</strong> of the gene and excludes the other allele. </p>\n<p class=\"p1\"><strong>B cells </strong>are <strong>diploid</strong>, therefore, each B cell has <strong>six gene segment pools </strong>related to antibody chains:</p>\n<ul>\n<li class=\"p1\"><strong>Two heavy-chain pools </strong>(one from each parent) and</li>\n<li class=\"p1\"><strong>Four light-chain pools </strong>(one κ and one λ from each parent).</li>\n</ul>\n<p class=\"p1\">However, <strong>each B cell uses</strong> <strong>only two</strong> of the six <strong>gene segment pools</strong>: one out of the two heavy-chain pools (maternal and paternal) and one out of the four light-chain pools. Thus, each B cell must choose not only between its κ and λ light-chain pools but also between its maternal and paternal light-chain and heavy-chain pools. This process of choosing is by <strong>allelic exclusion.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF7302",
      "difficulty": "medium"
    },
    {
      "text": "A 75-year-old woman with diabetes and hypertension has a biopsy of her heart that is shown below. What is the diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Dilated cardiomyopathy"
        },
        {
          "id": 2,
          "text": "Restrictive cardiomyopathy"
        },
        {
          "id": 3,
          "text": "Hypertrophic obstructive cardiomyopathy"
        },
        {
          "id": 4,
          "text": "Atrial fibrillation"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The<strong> hyaline, eosinophilic deposits</strong> seen on the biopsy point to a diagnosis of <strong>cardiac amyloidosis</strong>, which most commonly leads to <strong>restrictive cardiomyopathy. </strong></p>\n<p><strong>Transthyretin </strong>is the major component of <strong>senile cardiac amyloid</strong> deposits. It is<strong> </strong>a <strong>normal</strong> serum <strong>protein</strong> synthesized in the liver that <strong>transports</strong> <strong>thyroxine</strong> and <strong>retinol-binding protein. </strong>The deposits may accumulate <strong>subendocardially</strong>, and slowly expand - compressing the myocardial fibres - leading to pressure atrophy of myocaridial fibres. The stain used for amyloid deposits is <strong>congo red staining</strong>,<strong> </strong>which imparts<strong> pink to red color</strong> to the amyloid under <strong>ordinary light</strong> and <strong>apple-green birefringence</strong> under <strong>polarised microscopy.</strong></p>\n<p>Presentation of cardiac amyloidosis:</p>\n<ul>\n<li><strong>Restrictive cardiomyopathy- most common</strong></li>\n<li><strong>Asymptomatic</strong></li>\n<li>Dilation</li>\n<li>Arrhythmias</li>\n<li>Ischemic disease</li>\n</ul>\n<p>The echocardiographic findings in cardiac amyloidosis may include a <strong>distinctive granular, sparkling appearance of the thickened cardiac walls</strong>, representative of the infiltrative process. Despite the thickened ventricular walls, the ECG in cardiac amyloidosis typically demonstrates l<strong>ow limb lead voltage</strong>, often accompanied by <strong>ventricular conduction delay</strong> and pseudoinfarction patterns. Suspect cardiac amyloidosis when there is thickened ventricular walls with an ECG that shows low voltage. Amyloid infiltration can be detected with <strong>gadolinium enhancement on MRI.</strong></p>\n<p>A. Dilated cardiomyopathy/DCM is a condition in which the heart muscle becomes enlarged and weakened. This makes it difficult for the heart to pump blood effectively. DCM can be caused by a variety of factors, including coronary artery disease, high blood pressure, and diabetes. </p>\n<p>B. Hypertrophic cardiomyopathy/HOCM is a condition in which the IV septum becomes thickened and is typically genetic. On biopsy, <strong>myocardial disarray</strong> would be noted.</p>\n<p>D. Atrial fibrillation by rapid, irregularly irregular contractions of the atria that can lead to tachycardia induced cardiomyopathy. AF can be caused by a variety of factors, including heart disease, high blood pressure, and diabetes. </p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/aa3c283d27fc4d788789de1c221daff7.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG1016",
      "difficulty": "hard"
    },
    {
      "text": "A 62-year-old woman presents with a hard, irregular, fixed, and non-mobile lump in her breast. Her nipple is retracted, her skin is discolored, and her lymph nodes are enlarged. What does it mean if the tumor is luminal type A?",
      "choices": [
        {
          "id": 1,
          "text": "ER+ / HER2 neu-, mild to moderate proliferation"
        },
        {
          "id": 2,
          "text": "ER+ / HER2 neu+"
        },
        {
          "id": 3,
          "text": "ER- / HER2 neu-"
        },
        {
          "id": 4,
          "text": "ER+ / HER2 neu-, high proliferation"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Luminal type A breast cancer</strong> is defined as <strong>estrogen receptor (ER)</strong> and/or <strong>progesterone receptor (PR)</strong> <strong>positive</strong>, <strong>HER2-negative, and low to moderate Ki-67 proliferation index</strong>.</p>\n<p>This means that the tumor cells have ER and/or PR proteins on their surface and that they are not overexpressing the HER2 gene. The Ki-67 proliferation index is a marker of the rate of tumor proliferation. A low to moderate Ki-67 index indicates that the tumor cells are dividing slowly; ie: less aggressive.</p>\n<p><strong>Luminal type A</strong> breast cancer is the <strong>most common subtype of breast cancer</strong> and has the <strong>best prognosis</strong>. It is typically a <strong>low-grade, slow-growing tumor</strong> that is <strong>responsive to hormone therapy</strong>.</p>\n<p>Luminal A type is more commonly associated with <strong>BRCA2 </strong>mutations. Hormone receptor-positive tumors are <strong>responsive</strong> to hormonal chemotherapeutic agents like <strong>tamoxifen</strong> and<strong> aromatase inhibitors</strong>. In Her-2 negative cases, <strong>trastuzumab</strong> is not effective as it is a recombinant humanized monoclonal antibody directed <strong>against HER-2</strong>. </p>\n<table>\n<tbody>\n<tr>\n<td><strong>Molecular subtypes</strong> </td>\n<td><strong>ER</strong></td>\n<td><strong>PR</strong></td>\n<td><strong> HER2</strong></td>\n<td><strong>Ki-67</strong></td>\n<td><strong>Cytokeratin 5 and 6</strong></td>\n</tr>\n<tr>\n<td>\n<p><strong>Luminal A</strong></p>\n<p>(Most common type and has the best prognosis) </p>\n</td>\n<td>+ve</td>\n<td>+ve</td>\n<td>-ve</td>\n<td>Low</td>\n<td>-ve</td>\n</tr>\n<tr>\n<td><strong>Luminal B</strong></td>\n<td>+ve</td>\n<td>+ve</td>\n<td>-ve</td>\n<td>High</td>\n<td>-ve</td>\n</tr>\n<tr>\n<td> </td>\n<td>+ve</td>\n<td>+ve</td>\n<td>+ve</td>\n<td>Any</td>\n<td>-ve</td>\n</tr>\n<tr>\n<td><strong>HER2 enriched</strong></td>\n<td>-ve</td>\n<td>-ve</td>\n<td>+ve</td>\n<td>Any</td>\n<td>-ve</td>\n</tr>\n<tr>\n<td>\n<p><strong>Basal-like or Triple-negative breast cancer</strong></p>\n<p>(Aggressive, has worst prognosis but shows good response to chemotherapy, high PCR rates) </p>\n</td>\n<td>-ve</td>\n<td>-ve</td>\n<td>-ve</td>\n<td>Any</td>\n<td>+ve</td>\n</tr>\n<tr>\n<td>\n<p><strong>Unclassified</strong>, now also known as <strong>Claudin-low </strong></p>\n</td>\n<td>-ve</td>\n<td>-ve</td>\n<td>-ve</td>\n<td>Any</td>\n<td>-ve</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Option B: ER+ / <strong>HER2neu+</strong>: This is a separate subtype that is more <strong>aggressive, </strong>and responds to targeted chemotherapy.</p>\n<p>Option C: ER- / HER2neu-: <strong>ER-negative</strong> breast cancer is a subtype that is <strong>not responsive to hormone therapy.</strong></p>\n<p>Option D: ER+ / HER2neu-, <strong>high proliferation</strong>: This is a characteristic of <strong>luminal type B</strong> breast cancer, which is a <strong>more aggressive</strong> subtype than luminal type A.</p><hr><h3>Related Pearl: Molecular classification of breast cancer</h3><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Molecular subtypes&nbsp;</strong></td>\n<td>\n<p><strong>Receptor status </strong></p>\n</td>\n<td><strong>Histological subtypes</strong></td>\n</tr>\n<tr>\n<td>\n<p><strong>Luminal A type&nbsp;</strong></p>\n<p><strong>(most common,&nbsp;</strong>best prognosis)</p>\n<p>Mutated gene-&nbsp;BRCA 2</p>\n</td>\n<td>\n<p>ER/PR-&nbsp;+ve</p>\n<p>Her2- -ve</p>\n<p><strong>Ki-67-&nbsp;</strong></p>\n<p><strong>&lt;14% (low)</strong></p>\n</td>\n<td>\n<div class=\"page\" title=\"Page 1069\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Lobular carcinoma</p>\n<p>Mucinous carcinoma</p>\n<p>Tubular carcinoma</p>\n<p>Papillary carcinoma</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Luminal B type (HER2/neu negative)</strong></p>\n<p>Mutated gene-&nbsp;BRCA 2&nbsp;</p>\n</td>\n<td>\n<p>ER/PR-&nbsp;+ve</p>\n<p>Her2- -ve</p>\n<p><strong>Ki-67-&nbsp;</strong></p>\n<p><strong>&gt;14% (high)</strong></p>\n</td>\n<td>\n<div class=\"page\" title=\"Page 1064\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Poorly differentiated, lobular-carcinoma</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Luminal B type (HER2 positive)</strong></p>\n</td>\n<td>\n<p>ER/PR-&nbsp;+ve</p>\n<p>Her2- +ve</p>\n<p><strong>Ki-67-&nbsp;</strong></p>\n<p><strong>variable</strong></p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p><strong>HER2 enriched</strong></p>\n<p>Mutated gene-&nbsp;TP53</p>\n</td>\n<td>\n<p>ER/PR-&nbsp;-ve</p>\n<p>Her2- +ve</p>\n<p><strong>Ki-67-&nbsp;</strong></p>\n<p><strong>High&nbsp;</strong></p>\n</td>\n<td>\n<p>Apocrine carcinoma</p>\n<p>Micro-papillary carcinoma</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Basal type&nbsp;</strong><strong>(Triple-negative)</strong></p>\n<p>Mutated gene-&nbsp;BRCA 1</p>\n</td>\n<td>\n<p>ER/PR-&nbsp;-ve</p>\n<p>Her2- -ve</p>\n<p><strong>Ki-67-&nbsp;</strong></p>\n<p><strong>High</strong></p>\n</td>\n<td>\n<div class=\"page\" title=\"Page 1064\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Medullary carcinoma</p>\n<p>Adenoid cystic carcinoma</p>\n<p>Secretory carcinoma</p>\n<p>Metaplastic carcinoma</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>*Update: <strong>Claudin low-molecular subtype</strong>&nbsp;is a triple-negative breast cancer with low expression of E-cadherin, with a poor prognosis. It is frequently associated with lymphocyte infiltration.</p>\n<p>Almost all breast malignancies are adenocarcinomas and based on the expression of estrogen receptor and HER2 can be divided into three major biologic subgroups:</p>\n<ul>\n<li><strong>ER-positive HER2-negative tumors&nbsp;</strong>(50% to 65% of tumors) &ndash; range from well-differentiated cancers with low proliferative rates and few chromosomal changes to poorly differentiated cancers with high proliferative rates and large numbers of chromosomal rearrangements. All of these cancers express ER.</li>\n<li><strong>HER2-positive cancers - </strong>10% to 20% of tumors, which may either be ER-positive or ER-negative.</li>\n<li><strong>ER-negative, HER2-negative carcinomas&nbsp;</strong>(triple-negative or basal-like)- are characterized by genomic instability, a high proliferative rate, and expression of many proteins typical of myoepithelial cells (e.g., basal keratins).</li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Defining Features</strong></p>\n</td>\n<td>\n<p><strong>ER-positive, HER2- negative</strong></p>\n&nbsp;&nbsp;</td>\n<td>&nbsp;</td>\n<td>\n<p><strong>HER2- Positive (ER- positive or negative)</strong></p>\n</td>\n<td>\n<p><strong>ER- negative</strong></p>\n<p><strong>HER2- negative</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Frequency</p>\n</td>\n<td>\n<p>~40-55% (Low proliferation)</p>\n</td>\n<td>\n<p>~10% (High proliferation)</p>\n</td>\n<td>\n<p>~20%</p>\n</td>\n<td>\n<p>~15%</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Included special histologic types</p>\n</td>\n<td>\n<p>Well or moderately differentiated lobular, tubular, mucinous</p>\n</td>\n<td>\n<p>Poorly differentiated lobular</p>\n</td>\n<td>\n<p>Some apocrine</p>\n</td>\n<td>\n<p>Medullary, adenoid cystic, secretory, metaplastic</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Typical patient groups</p>\n</td>\n<td>\n<p>Older women, men, cancers detected by mammographic screening</p>\n</td>\n<td>\n<p><em>BRCA2</em> mutation carriers</p>\n</td>\n<td>\n<p>Young women, non-white women, <em>TP53</em> mutation carrier (ER-positive)</p>\n</td>\n<td>\n<p>Young women, <em>BRCA1 </em>mutation carriers, African American and Hispanic women</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG0992",
      "difficulty": "medium"
    },
    {
      "text": "A 60-year-old vegetarian presents with fatigue and weakness that have been present for a few months. On physical examination, pallor is noted. Hemoglobin is 9 g/dL and MCV is increased at 110 fL. What is the most likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Iron deficiency anemia"
        },
        {
          "id": 2,
          "text": "Megaloblastic anemia"
        },
        {
          "id": 3,
          "text": "Aplastic anemia"
        },
        {
          "id": 4,
          "text": "Thalassemia"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p data-sourcepos=\"7:1-7:95\">The most likely diagnosis in this case is <strong>megaloblastic anemia</strong>, given the patient's <strong>vegetarian diet, macrocytosis, and low hemoglobin level.</strong></p>\n<p data-sourcepos=\"19:1-19:336\">Megaloblastic anemia can be caused by a deficiency of vitamin B12 or folate. Vegetarians are at increased risk of vitamin B12 deficiency because vitamin B12 is primarily found in animal products. Other conditions can also cause megaloblastic anemia, such as <strong>celiac disease, Crohn's disease, and ulcerative colitis</strong>. Other causes of high MCV,<span class=\"animating\"> such as <strong>liver disease,</strong></span><strong><span class=\"animating\"> alcoholism,</span><span class=\"animating\"> and hypothyroidism.</span></strong></p>\n<p data-sourcepos=\"7:1-7:95\"><strong>Iron deficiency anemia</strong> is characterized by a low hemoglobin level and a microcytic (small cell) anemia. Iron is essential for the production of hemoglobin, and a deficiency of iron can lead to a decrease in hemoglobin levels. However, IDA is typically associated with a low MCV, not a high MCV.</p>\n<p data-sourcepos=\"11:1-11:101\"><strong>In Aplastic anemia</strong> the bone marrow does not produce enough progenitor cells. It can be caused by autoimmune diseases, medications, and radiation. Aplastic anemia can lead to a decrease in all types of blood cells and is associated with a low MCV and a low hemoglobin level, not a high MCV.</p>\n<p data-sourcepos=\"13:1-13:234\"><strong>Thalassemia </strong>is a group of genetic blood disorders that affect the production of hemoglobin. It is characterized by a microcytic anemia. However, thalassemia is not typically associated with a high MCV.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG1036",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following proteins shows a marked increase in size in nephrotic syndrome on serum electrophoresis?",
      "choices": [
        {
          "id": 1,
          "text": "Albumin"
        },
        {
          "id": 2,
          "text": "Alpha 2 globulin"
        },
        {
          "id": 3,
          "text": "Beta globulin"
        },
        {
          "id": 4,
          "text": "Gamma globulin"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<div class=\"ng-star-inserted\">\n<div class=\"table-responsive font-weight-light answer-scroll answer-html ng-star-inserted\">\n<p><strong>Alpha 2 globulin </strong>becomes relatively more<strong> prominent in nephrotic syndrome.</strong></p>\n<p><strong>Alpha 2  globulin</strong>, being a relatively large compared to others is <strong>not lost through urine as it is unable to pass through the glomeruli</strong> in nephrotic syndrome. Hence the α2 band which includes α2 macroglobulin is very prominent in serum protein electrophoresis of a nephrotic syndrome patient.</p>\n<p>ALL proteins are lost in nephrotic syndrome and their size is relatively reducied, except alpha 2 globulin:</p>\n<p>Albumin is the most abundant protein in the blood and is responsible for maintaining osmotic pressure. In nephrotic syndrome, albumin leaks out of the glomeruli into the urine. This leads to a decrease in serum albumin levels, but the remaining albumin molecules may become larger due to increased glycosylation.</p>\n<p>Beta globulins are a group of proteins that play a role in transporting hormones and other molecules in the blood.</p>\n<p>Gamma globulin: Gamma globulins are a group of proteins that play a role in immunity. </p>\n<p> The following image shows the bands with their corresponding proteins in <strong>normal</strong> serum electrophoresis.</p>\n</div>\n</div>\n<div class=\"ng-star-inserted\">\n<div class=\"ng-star-inserted\">\n<div class=\"h-400-scroll mb-2 ng-star-inserted\"><img class=\"img-fluid hover-max\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/fbd0983139604b11ad59a24ebd1bfdefx1280x606.JPEG\" /></div>\n</div>\n</div>\n<div class=\"ng-star-inserted\">\n<div class=\"table-responsive font-weight-light answer-scroll answer-html ng-star-inserted\">\n<p>Certain common diseases and their electrophoretic pattern:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Condition</strong></td>\n<td><strong> Electrophoretic pattern</strong></td>\n</tr>\n<tr>\n<td>Chronic infections</td>\n<td>Smooth increase in gamma globulins</td>\n</tr>\n<tr>\n<td>Multiple myeloma</td>\n<td>Gamma globulin part is increased (<strong>M BAND</strong>)</td>\n</tr>\n<tr>\n<td>Liver cirrhosis</td>\n<td>Reduced albumin and compensatory increase in globulin</td>\n</tr>\n<tr>\n<td>Primary immune deficiency</td>\n<td>Gamma globulin reduced</td>\n</tr>\n<tr>\n<td>α1 antitrypsin deficiency</td>\n<td>α1 band is thin and even lost sometimes</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG1034",
      "difficulty": "medium"
    },
    {
      "text": "Seminomas are positive for which of the following immunohistochemistry markers?<div class='question-desc-html'><ol>\n<li>PLAP</li>\n<li>OCT4</li>\n<li>KIT</li>\n<li>HCG</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1, 2, 3"
        },
        {
          "id": 2,
          "text": "1, 2, 3, 4"
        },
        {
          "id": 3,
          "text": "2, 3, 4"
        },
        {
          "id": 4,
          "text": "1, 3, 4"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>A seminoma would exhibit positivity for <strong>PLAP, OCT4, and KIT</strong> (Also <strong>NANOG</strong>)</p>\n<ul>\n<li aria-level=\"1\"><strong>PLAP</strong> (placental alkaline phosphatase): PLAP is a germ cell tumor marker that is positive in s<strong>eminomas, dysgerminomas, and embryonal carcinomas.</strong></li>\n<li aria-level=\"1\"><strong>OCT4</strong> (octamer-binding transcription factor 4): OCT4 is a pluripotency marker that is positive in <strong>seminomas, dysgerminomas, and embryonal carcinomas.</strong></li>\n<li aria-level=\"1\"><strong>KIT</strong> (KIT proto-oncogene receptor tyrosine kinase): KIT is a tyrosine kinase receptor that is positive in <strong>seminomas and dysgerminomas.</strong></li>\n<li aria-level=\"1\"><strong>hCG</strong> (human chorionic gonadotropin): HCG is a pregnancy hormone that is produced by the syncytiotrophoblast cells of the placenta. HCG is sometimes positive in <strong>other </strong>types of<strong> germ cell tumors</strong>, such as <strong>choriocarcinomas and yolk sac tumors, but not typically in seminomas. </strong>About <strong>15% </strong>of seminomas that <strong>contain syncytiotrophoblasts</strong> may be associated with a <strong>raised beta hCG</strong> <strong>but</strong> even in these patients the levels are <strong>not as high as those seen in choriocarcinoma</strong>.</li>\n<li aria-level=\"1\"><strong>NANOG</strong> (homeobox protein NANOG): NANOG is a pluripotency marker that is positive in <strong>seminomas, dysgerminomas, and embryonal carcinomas. </strong></li>\n</ul>\n<p> Seminoma is the <strong>most common</strong> type of germ cell tumor (~50% of GCTs). The peak incidence is seen in the fourth decade. It is the testicular equivalent of an ovarian dysgerminoma, or the pineal gland tumor termed germinoma. The gross specimen shows a homogeneous, grey-white, lobulated cut surface, devoid of hemorrhage or necrosis.</p>\n<p>Histopathological examination shows sheets of uniform cells with clear cytoplasm and central nucleus, with a prominent nucleolus <strong>(fried-egg appearance)</strong>. The sheets of cells are poorly demarcated into lobules by delicate fibrous septa containing a lymphocytic infiltrate. Immunohistochemistry is positive for <strong>KIT, OCT3/4, placental alkaline phosphatase (PLAP), and podoplanin and negative for cytokeratin. </strong>Lactate dehydrogenase (<strong>LDH</strong>) levels are also measured to assess <strong>tumor burden</strong>. It usually presents as painless testicular enlargement. A heaviness may be felt if the size is 2-3 times normal. Rarely, it may present with symptoms of metastatic disease. Sonography is mandatorily done in all suspected cases.</p>\n<p><strong>Tumor markers</strong> which may be <strong>elevated in up to 50% of cases</strong>, should be investigated prior to orchiectomy. This serves as useful in <strong>follow-up after surgery. </strong>An <strong>orchidectomy</strong> through an inguinal incision is performed as a definitive treatment. Surveillance using CT imaging and tumor marker to look for metastasis or relapse is done. Histopathologic diagnosis also helps to plan <strong>radiotherapy or chemotherapy.</strong></p>\n<p>Note:<strong> </strong>Since ~85% of seminomas are not positive for HCG, option 1,2,3 is a better one to choose.</p><hr><h3>Related Pearl: Tumor Markers in Testicular Germ Cell Tumors</h3><table>\n<tbody>\n<tr>\n<td>\n<p> </p>\n</td>\n<td>\n<p>AFP</p>\n</td>\n<td>\n<p>b-hCG</p>\n</td>\n<td>\n<p>LDH</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Seminoma</p>\n</td>\n<td>\n<p> -</p>\n</td>\n<td>\n<p>+</p>\n</td>\n<td>\n<p>++</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Yolk sac tumor</p>\n</td>\n<td>\n<p>+++</p>\n</td>\n<td>\n<p>+</p>\n</td>\n<td>\n<p>+</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Choriocarcinoma</p>\n</td>\n<td>\n<p> -</p>\n</td>\n<td>\n<p>+++</p>\n</td>\n<td>\n<p>+</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Embryonal carcinoma</p>\n</td>\n<td>\n<p>+</p>\n</td>\n<td>\n<p>+</p>\n</td>\n<td>\n<p>++</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Teratoma</p>\n</td>\n<td>\n<p> - </p>\n</td>\n<td>\n<p> -</p>\n</td>\n<td>\n<p> -</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> Note:</p>\n<p><strong> Alpha-fetoprotein AFP</strong>: Raised in</p>\n<ul>\n<li>Embryonal carcinoma</li>\n<li>Yolk sac tumor</li>\n<li>Teratocarcinoma</li>\n<li>Mixed germ cell tumor</li>\n</ul>\n<p>AFP is never raised in pure seminomas or pure choriocarcinoma</p>\n<p><strong>Human chorionic gonadotropin (HCG): </strong>Only the β subunit is measured by the most commonly available serum assays. Can be raised in</p>\n<ul>\n<li>Choriocarcinoma</li>\n<li>Embryonal carcinoma</li>\n<li>Teratocarcinoma</li>\n<li>Seminoma (only in about 15% Seminomas)</li>\n<li>Mixed germ-cell tumors</li>\n</ul>\n<p> <strong>Lactate dehydrogenase (</strong><strong>LDH):</strong></p>\n<ul>\n<li>LDH has limited sensitivity and specificity for seminoma, but LDH levels &gt;2000 U/L are more consistent with bulky disease, and rising levels are an accurate indicator of recurrence.</li>\n<li> In non-seminomatous germ-cell tumors (NSCGT), LDH is directly related to tumor burden.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG0996",
      "difficulty": "medium"
    },
    {
      "text": "Match the following genes with their associated cancer types:<div class='question-desc-html'><table data-sourcepos=\"5:1-10:28\">\n<tbody>\n<tr data-sourcepos=\"7:1-7:39\">\n<td data-sourcepos=\"7:1-7:5\">1. KIT</td>\n<td data-sourcepos=\"7:7-7:38\"> A. Myeloproliferative disorders</td>\n</tr>\n<tr data-sourcepos=\"8:1-8:23\">\n<td data-sourcepos=\"8:1-8:6\">2. KRAS</td>\n<td data-sourcepos=\"8:8-8:22\"> B. Lung cancer</td>\n</tr>\n<tr data-sourcepos=\"9:1-9:52\">\n<td data-sourcepos=\"9:1-9:7\">3. JAK 2</td>\n<td data-sourcepos=\"9:9-9:51\"> C. Gastrointestinal stromal tumors (GISTs)</td>\n</tr>\n<tr data-sourcepos=\"10:1-10:28\">\n<td data-sourcepos=\"10:1-10:5\">4. ALK</td>\n<td data-sourcepos=\"10:7-10:27\"> D. Pancreatic cancer</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div></div>",
      "choices": [
        {
          "id": 1,
          "text": "1B, 2C, 3A, 4D"
        },
        {
          "id": 2,
          "text": "1C, 2D, 3A, 4B"
        },
        {
          "id": 3,
          "text": "1C, 2B, 3A, 4D"
        },
        {
          "id": 4,
          "text": "1A, 2B, 3D, 4C"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<div class=\"horizontal-scroll-wrapper\">\n<div class=\"table-block-component\">\n<div class=\"table-block\">\n<div class=\"table-content\">\n<table data-sourcepos=\"1:1-6:326\">\n<tbody>\n<tr data-sourcepos=\"1:1-1:36\">\n<th data-sourcepos=\"1:1-1:6\">Gene</th>\n<th data-sourcepos=\"1:8-1:20\">Cancer type</th>\n<th data-sourcepos=\"1:22-1:34\">Explanation</th>\n</tr>\n<tr data-sourcepos=\"3:1-3:174\">\n<td data-sourcepos=\"3:1-3:5\">KIT</td>\n<td data-sourcepos=\"3:7-3:47\">Gastrointestinal stromal tumors (GISTs)</td>\n<td data-sourcepos=\"3:49-3:172\">KIT mutations are found in about 85% of GISTs. GISTs are the most common mesenchymal tumors of the gastrointestinal tract.</td>\n</tr>\n<tr data-sourcepos=\"4:1-4:162\">\n<td data-sourcepos=\"4:1-4:6\">KRAS</td>\n<td data-sourcepos=\"4:8-4:26\">Pancreatic cancer</td>\n<td data-sourcepos=\"4:28-4:160\">KRAS mutations are found in about 90% of pancreatic cancers. Pancreatic cancer is a highly aggressive cancer with a poor prognosis.</td>\n</tr>\n<tr data-sourcepos=\"5:1-5:273\">\n<td data-sourcepos=\"5:1-5:7\">JAK 2</td>\n<td data-sourcepos=\"5:9-5:38\">Myeloproliferative disorders</td>\n<td data-sourcepos=\"5:40-5:271\">JAK 2 mutations are found in a variety of myeloproliferative disorders, including polycythemia vera, essential thrombocythemia, and myelofibrosis. Myeloproliferative disorders are characterized by an overproduction of blood cells.</td>\n</tr>\n<tr data-sourcepos=\"6:1-6:326\">\n<td data-sourcepos=\"6:1-6:5\">ALK</td>\n<td data-sourcepos=\"6:7-6:45\">Leukemia/myeloproliferative disorders</td>\n<td data-sourcepos=\"6:47-6:324\">ALK mutations are found in a variety of leukemias and myeloproliferative disorders, including anaplastic large cell lymphoma and chronic myeloid leukemia. It is also seen in some non small cell lung cancers.</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n</div>\n<div class=\"table-footer hide-from-message-actions ng-star-inserted\"> </div>\n<div class=\"table-footer hide-from-message-actions ng-star-inserted\"> </div>\n</div>\n</div>\n</div><hr><h3>Related Pearl: Cancers associated with important oncogenes</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Oncogenes</strong></p>\n</td>\n<td><strong>Associated cancers</strong></td>\n</tr>\n<tr>\n<td>\n<p><em>c-MYC</em></p>\n</td>\n<td>\n<p>Burkitt&rsquo;s lymphoma</p>\n<p>Adenocarcinomas of the breast, lung, and colon</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><em>N-MYC</em></p>\n</td>\n<td>\n<p>Neuroblastoma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><em>L-MYC</em></p>\n</td>\n<td>\n<p>Small-cell carcinoma of the lung</p>\n</td>\n</tr>\n<tr>\n<td><em>K-RAS</em></td>\n<td>Colon, lung, and pancreatic tumors</td>\n</tr>\n<tr>\n<td><em>N-RAS</em></td>\n<td>\n<p>Melanoma</p>\n<p>AML</p>\n</td>\n</tr>\n<tr>\n<td><em>H-RAS</em></td>\n<td>Bladder and kidney tumors</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG1000",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following stains are used in the cervical smear below?",
      "choices": [
        {
          "id": 1,
          "text": "Papanicolau stain"
        },
        {
          "id": 2,
          "text": "Toluidene blue"
        },
        {
          "id": 3,
          "text": "H & E stain"
        },
        {
          "id": 4,
          "text": "Giemsa stain"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The cervical smear shown above is stained with <strong>Papanicolau stain</strong>. Pap stain is the most commonly used stain for cervical smears. It is a <strong>polychrome stain that stains different cell types different colors</strong>, making it easy to identify abnormal cells.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Type of cell</strong></td>\n<td><strong>Identification feature</strong></td>\n</tr>\n<tr>\n<td>Basal &amp; Para Basal</td>\n<td>Cells are small, rounded, <strong>basophilic</strong> with large nuclei<strong> </strong></td>\n</tr>\n<tr>\n<td>Middle layer (Intermediate)</td>\n<td>Cells are squamous cells, transparent and <strong>basophilic (Blue/Green)</strong> with vesicular nuclei</td>\n</tr>\n<tr>\n<td>Superficial layer</td>\n<td>Cells are acidophilic (<strong>Pink</strong>), with pyknotic nuclei</td>\n</tr>\n<tr>\n<td>Malignant cells</td>\n<td>Hyperchromatic, nuclei vary in size, small cytoplasm in undifferentiated malignant cells</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>                </p>\n<div class=\"ng-star-inserted\">\n<div class=\"ng-star-inserted\">\n<div class=\"h-400-scroll mb-2 ng-star-inserted\"><img class=\"img-fluid hover-max\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/eae28d45d3a14a45b89d1baf74965ed7x1280x1022.JPEG\" /></div>\n</div>\n</div>\n<div class=\"ng-star-inserted\">\n<div class=\"table-responsive font-weight-light answer-scroll answer-html ng-star-inserted\">\n<p>The above image shows superficial cells (arrow mark) along with other basophilic cells.</p>\n</div>\n</div>\n<p><strong> Toluidine blue stain:</strong> Toluidine blue stain is a metachromatic stain that stains acidic and basic substances different colors. It is commonly used to stain mast cells and other cells that contain acidic and basic granules.</p>\n<p><strong>Hematoxylin and eosin stain (H&amp;E stain):</strong> H&amp;E stain is a polychrome stain that stains nuclei blue and cytoplasm pink. It is commonly used to stain tissue sections for histological examination.</p>\n<p><strong>Giemsa stain:</strong> Giemsa stain is a polychrome stain that stains nuclei blue and cytoplasm pink. It is commonly used to stain blood smears and bone marrow aspirates.</p>\n<p data-sourcepos=\"12:1-12:232\"> </p>\n<table data-sourcepos=\"1:1-6:178\">\n<tbody>\n<tr data-sourcepos=\"1:1-1:16\">\n<th data-sourcepos=\"1:1-1:7\">Stain</th>\n<th data-sourcepos=\"1:9-1:14\">Uses</th>\n</tr>\n<tr data-sourcepos=\"3:1-3:268\">\n<td data-sourcepos=\"3:1-3:32\">Papanicolaou stain (Pap stain)</td>\n<td data-sourcepos=\"3:34-3:266\">Screening for cervical cancer and precancerous lesions, diagnosis of other gynecological conditions such as endometrial cancer and vulvar cancer, diagnosis of urinary tract infections and other conditions of the bladder and urethra</td>\n</tr>\n<tr data-sourcepos=\"4:1-4:148\">\n<td data-sourcepos=\"4:1-4:22\">Toluidine blue stain</td>\n<td data-sourcepos=\"4:24-4:146\">Diagnosis of mast cell disorders, detection of acidic and basic granules in cells, diagnosis of certain fungal infections</td>\n</tr>\n<tr data-sourcepos=\"5:1-5:135\">\n<td data-sourcepos=\"5:1-5:45\">Hematoxylin and eosin stain (H&amp;E stain)</td>\n<td data-sourcepos=\"5:47-5:133\">Histological examination of tissue sections for a wide variety of diagnostic purposes</td>\n</tr>\n<tr data-sourcepos=\"6:1-6:178\">\n<td data-sourcepos=\"6:1-6:14\">Giemsa stain</td>\n<td data-sourcepos=\"6:16-6:176\">Staining blood smears and bone marrow aspirates for the diagnosis of blood disorders, diagnosis of parasitic infections, diagnosis of certain fungal infections</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/f250eb898ae14990ba9bcb974a944a25.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG1037",
      "difficulty": "easy"
    },
    {
      "text": "A woman presents with a fixed nodule in her breast with nipple retraction. Biopsy shows HER2/neu positivity. What chromogen is responsible for the brown color in the immunohistochemical stain?",
      "choices": [
        {
          "id": 1,
          "text": "FITC"
        },
        {
          "id": 2,
          "text": "Diaminobenzidine"
        },
        {
          "id": 3,
          "text": "Cyanate"
        },
        {
          "id": 4,
          "text": "Phycoerythrin"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>DAB (3,3ʹ-diaminobenzidine)</strong> is a chromogen that is used in immunohistochemistry. It produces a <strong>brown precipitate </strong>when exposed to<strong> hydrogen peroxide and horseradish peroxidase. </strong>DAB is the most commonly used chromogen in immunohistochemistry because it produces a strong and <strong>stable color</strong>. It is also relatively <strong>inexpensive and easy to use.</strong></p>\n<p><strong><img class=\"img-fluid hover-max\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2644a3a7e0ce4bf38e37ad36d717dd33x243x199.JPEG\" /></strong></p>\n<p>In IHC, a primary antibody is applied to the tissue sample. The primary antibody binds to the protein of interest. A secondary antibody is then applied to the tissue sample. The secondary antibody binds to the primary antibody. The secondary antibody is conjugated to an enzyme, such as horseradish peroxidase. When the tissue sample is exposed to hydrogen peroxide, the enzyme catalyzes the production of a free radical. The free radical then reacts with the chromogen to produce a colored precipitate.The <strong>color of the precipitate depends on the chromogen</strong> that is used. </p>\n<p>Other options:</p>\n<p><strong>FITC (fluorescein isothiocyanate)</strong>: FITC is a fluorescent chromogen that is used in immunofluorescence staining and flow cytometry. It produces a <strong>green</strong> fluorescence when excited by light at 488 nm.</p>\n<p><strong>Cyanate is a colorless</strong> compound that can be used to <strong>conjugate antibodies</strong> to other molecules. <strong>Alkaline phosphatase</strong> is an enzyme that is used in immunohistochemistry to <strong>amplify the signal</strong> from the primary antibody. It <strong>does not produce a color</strong> by itself.</p>\n<p><strong>Phycoerythrin</strong> is a fluorescent chromogen that is used in flow cytometry. It produces a <strong>red fluorescence</strong> when excited by light at <strong>561 nm. </strong></p>\n<p> </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG1011",
      "difficulty": "easy"
    },
    {
      "text": "Transferrin saturation is decreased in which of the following conditions?",
      "choices": [
        {
          "id": 1,
          "text": "Hemosiderosis"
        },
        {
          "id": 2,
          "text": "Iron deficiency anemia"
        },
        {
          "id": 3,
          "text": "Hemochromatosis"
        },
        {
          "id": 4,
          "text": "Pernicious anemia"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p> </p>\n<p>The correct answer is <strong>iron deficiency anemia</strong>. <strong>Transferrin saturation</strong> is a measure of the <strong>percentage of transferrin molecules that are saturated with iron</strong>. Transferrin is a protein that transports iron in the blood - normal saturation is between <strong>20% and 50%</strong>.In iron deficiency anemia, the body does not have enough iron to saturate all of the transferrin molecules -&gt; decreased transferrin saturation. Note: transferrin saturation can be affected by <strong>inflammation, infection, and liver disease.</strong></p>\n<table>\n<tbody>\n<tr>\n<td>Test</td>\n<td>Normal range</td>\n<td>Increased in:</td>\n<td>Decreased in:</td>\n</tr>\n<tr>\n<td>Transferrin</td>\n<td>200-400 mg/dL</td>\n<td>Iron deficiency anemia</td>\n<td>Inflammation, infection, liver disease, nephrotic syndrome</td>\n</tr>\n<tr>\n<td>Total iron binding capacity (TIBC)</td>\n<td>250-450 µg/dL</td>\n<td>Iron deficiency anemia</td>\n<td>Chronic inflammatory disease, anemia of chronic disease, kidney disease</td>\n</tr>\n<tr>\n<td>Ferritin</td>\n<td>20-250 ng/mL</td>\n<td>Hemochromatosis, infection, inflammation, malignancy</td>\n<td>Iron deficiency anemia, chronic inflammatory disease, anemia of chronic disease</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p>\n<p>Hemosiderosis: Hemosiderosis is a condition in which there is excess iron deposition in the tissues. Transferrin saturation is typically normal/increased in hemosiderosis.</p>\n<p>Hemochromatosis: Hemochromatosis is a condition in which the body absorbs too much iron. Transferrin saturation is typically elevated in hemochromatosis.</p>\n<p>Pernicious anemia: Pernicious anemia is a type of anemia caused by a deficiency of vitamin B12. Transferrin saturation is typically normal in pernicious anemia.</p><hr><h3>Related Pearl: Differential Diagnosis of Microcytic Anaemia</h3><table>\n<tbody>\n<tr>\n<td>Investigation</td>\n<td><strong>Iron- Deficiency Anemia</strong></td>\n<td><strong>Alpha or beta thalassemia</strong></td>\n<td><strong>Anemia of Chronic Disease</strong></td>\n</tr>\n<tr>\n<td><strong>Serum Iron</strong></td>\n<td>&lt;60 &micro;g/dL</td>\n<td>Normal/Increased</td>\n<td>Decreased</td>\n</tr>\n<tr>\n<td><strong>Serum Ferritin</strong></td>\n<td>&lt;20 &micro;g/L</td>\n<td>Normal/Increased</td>\n<td>Increased</td>\n</tr>\n<tr>\n<td><strong>TIBC</strong></td>\n<td>Increased</td>\n<td>Normal</td>\n<td>Decreased</td>\n</tr>\n<tr>\n<td><strong>Transferrin saturation</strong></td>\n<td>&lt;15%</td>\n<td>Normal</td>\n<td>Normal/Decreased</td>\n</tr>\n<tr>\n<td><strong>MCV</strong></td>\n<td>Decreased</td>\n<td>&nbsp;Decreased</td>\n<td>Normal/Decreased</td>\n</tr>\n<tr>\n<td><strong>RBC count</strong></td>\n<td>Decreased</td>\n<td>Normal/Increased</td>\n<td>Normal/Increased</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>TIBC: Total iron-binding capacity&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG1020",
      "difficulty": "easy"
    },
    {
      "text": "Post-orchidectomy, a patient's histopathology slide showed rods of Reinke's crystalloids. Which of the following conditions is associated with this?",
      "choices": [
        {
          "id": 1,
          "text": "Gonadoblastoma"
        },
        {
          "id": 2,
          "text": "Sertoli cell tumor"
        },
        {
          "id": 3,
          "text": "Leydig cell tumor"
        },
        {
          "id": 4,
          "text": "Yolk sac tumor"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Reinke's crystalloids</strong> are rod-shaped or corn-shaped structures that are found in <strong>Leydig cells, and seen in Leydig cell tumors.</strong> They are made of <strong>calretinin</strong>. Leydig cell tumors are usually benign, but they can sometimes be malignant.</p>\n<p>This is the most common sex-cord stromal type of testicular neoplasm. It is mostly <strong>benign</strong> and invariably <strong>unilateral. </strong>Most cases occur between 20 and 60 years of age. However, they can present at any age. The most common presenting feature is <strong>testicular swelling </strong>or<strong> gynecomastia</strong> (~15% of cases). In children, hormonal effects manifested <strong>primarily </strong>as<strong> sexual precocity</strong>, are the dominant features. Tumors of Leydig cells may secrete <strong>androgens </strong>and<strong> estrogens</strong>, and even<strong> corticosteroids.</strong></p>\n<p>Grossly it shows <strong>golden brown, homogeneous circumscribed</strong> nodules &lt;5 cm in diameter. Histologically:</p>\n<ul>\n<li>large, round, or polygonal cells</li>\n<li>round central nucleus and prominent nucleoli</li>\n<li>abundant granular eosinophilic cytoplasm containing lipid droplets, vacuoles, or lipofuscin pigment</li>\n<li><strong>crystalloids of Reinke</strong>, rod-shaped eosinophilic cytoplasmic bodies are seen in about 25% of the tumors</li>\n</ul>\n<p>Other options:</p>\n<p>Option A: <strong>Gonadoblastoma</strong> is a rare mixed germ cell-sex cord stromal tumor that occurs in the gonads of patients with dysgenetic gonads.</p>\n<p>Option B: <strong>Sertoli cell tumor</strong> is a rare tumor that arises from Sertoli cells, which are supporting cells in the testes. <strong>Sertoli cells,</strong> with a <strong>thickening of the tubular basement membrane</strong> and <strong>absence</strong> of<strong> germ cells</strong> which is characteristic of Sertoli cell-only syndrome.</p>\n<p>Option D: <strong>Yolk sac tumor</strong> is a type of germ cell tumor that is most common in children. <strong>Schiller Duval bodies</strong> are seen in<strong> yolk sac tumors </strong>and resemble endodermal sinuses. They resemble glomerulus-like structures in the visceral and parietal layer while the central core consists of capillaries. </p><hr><h3>Related Pearl: WHO 2016 classification of testicular tumors</h3><div class=\"page\" title=\"Page 182\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>I. Germ-cell tumors (GCTs) derived from germ-cell neoplasia in situ</strong></p>\n<ul>\n<li>Germ-cell neoplasia in situ</li>\n<li>Seminoma</li>\n<li>Non-seminomatous GCTs\n<ul>\n<li>Embryonal carcinoma</li>\n<li>Yolk sac tumor, postpubertal-type</li>\n<li>Choriocarcinoma</li>\n<li>Teratoma, post-pubertal type</li>\n</ul>\n</li>\n<li>Mixed germ-cell tumors</li>\n</ul>\n<p><strong>II. Germ-cell tumors unrelated to germ-cell neoplasia in situ</strong></p>\n<ul>\n<li>Spermatocytic tumour</li>\n<li>Teratoma, prepubertal type</li>\n<li>Yolk sac tumor, prepubertal type</li>\n<li>Mixed</li>\n</ul>\n<p><strong>III. Sex cord stromal tumors</strong></p>\n<ul>\n<li>Leydig cell tumor</li>\n<li>Sertoli cell tumor</li>\n<li>Granulosa cell tumor</li>\n<li>Fibroma&ndash;thecoma</li>\n</ul>\n<p><strong>IV. Tumor containing both germ-cell and sex cord-stromal elements</strong></p>\n<ul>\n<li>Gonadoblastoma</li>\n</ul>\n<p><strong>V. Hematolymphoid tumors</strong></p>\n</div>\n</div>\n</div>\n</div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/b559bf19d0394a0cbdc52a1cae041366.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG1014",
      "difficulty": "medium"
    },
    {
      "text": "Match the following genetic disorders with their inheritance patterns:<div class='question-desc-html'><table data-sourcepos=\"5:1-10:42\">\n<tbody>\n<tr data-sourcepos=\"7:1-7:40\">\n<td data-sourcepos=\"7:0-7:18\">A. Cystic fibrosis</td>\n<td data-sourcepos=\"7:20-7:39\"> 1. Autosomal dominant</td>\n</tr>\n<tr data-sourcepos=\"8:1-8:41\">\n<td data-sourcepos=\"8:0-8:25\">B. Leber optic neuropathy</td>\n<td data-sourcepos=\"8:27-8:40\"> 2. Autosomal recessive</td>\n</tr>\n<tr data-sourcepos=\"9:1-9:51\">\n<td data-sourcepos=\"9:0-9:30\">C. Duchenne muscular dystrophy</td>\n<td data-sourcepos=\"9:32-9:50\"> 3. X-Linked recesssive</td>\n</tr>\n<tr data-sourcepos=\"10:1-10:42\">\n<td data-sourcepos=\"10:0-10:21\">D. Myotonic dystrophy</td>\n<td data-sourcepos=\"10:23-10:41\"> 4. Mitochondrial</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div></div>",
      "choices": [
        {
          "id": 1,
          "text": "A2, B4, C3, D1"
        },
        {
          "id": 2,
          "text": "A3, B4, C2, D1"
        },
        {
          "id": 3,
          "text": "A1, B4, C3, D2"
        },
        {
          "id": 4,
          "text": "A2, B4, C1, D3"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<table data-sourcepos=\"5:1-10:42\">\n<tbody>\n<tr data-sourcepos=\"5:1-5:46\">\n<th data-sourcepos=\"5:0-5:20\"><strong>Genetic disorder</strong></th>\n<th data-sourcepos=\"5:22-5:45\"><strong>Inheritance pattern</strong></th>\n</tr>\n<tr data-sourcepos=\"7:1-7:40\">\n<td data-sourcepos=\"7:0-7:18\">A. Cystic fibrosis</td>\n<td data-sourcepos=\"7:20-7:39\">Autosomal recessive</td>\n</tr>\n<tr data-sourcepos=\"8:1-8:41\">\n<td data-sourcepos=\"8:0-8:25\">B. Leber optic neuropathy</td>\n<td data-sourcepos=\"8:27-8:40\">Mitochondrial</td>\n</tr>\n<tr data-sourcepos=\"9:1-9:51\">\n<td data-sourcepos=\"9:0-9:30\">C. Duchenne muscular dystrophy</td>\n<td data-sourcepos=\"9:32-9:50\">X-linked recessive</td>\n</tr>\n<tr data-sourcepos=\"10:1-10:42\">\n<td data-sourcepos=\"10:0-10:21\">D. Myotonic dystrophy</td>\n<td data-sourcepos=\"10:23-10:41\">Autosomal dominant</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Cystic fibrosis:</strong> Cystic fibrosis is an autosomal recessive genetic disorder; both parents must carry a copy of the mutated gene in order for the child to be affected.</p>\n<p><strong>Leber optic neuropathy:</strong> Leber optic neuropathy is a mitochondrial genetic disorder. This means that the mutated gene is located on the mitochondrial DNA, which is DNA that is <strong>outside of the nucleus</strong> of the cell. Mitochondrial DNA is inherited solely from the <strong>mother.</strong></p>\n<p><strong>Duchenne muscular dystrophy:</strong> Duchenne muscular dystrophy is an X-linked recessive genetic disorder. This means that the mutated gene is located on the X chromosome. <strong>Males</strong> have only one X chromosome, so if they inherit a mutated copy of the gene, they will be affected. Females have two X chromosomes, so if they inherit one mutated copy of the gene, they will be<strong> carriers.</strong></p>\n<p><strong>Myotonic dystrophy:</strong> Myotonic dystrophy is an autosomal dominant genetic disorder. This means that only one parent needs to carry a copy of the mutated gene in order for their child to be affected.</p><hr><h3>Related Pearl: Inheritance pattern of important diseases</h3><table class=\"t1\">\n<tbody>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>Autosomal dominant</strong></span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>Autosomal recessive</strong></span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>HEAV</strong>y<strong> DOMINANT</strong></span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>ABC DEF GHI</strong></span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>H</strong>: <strong>H</strong>ereditary spherocytosis, <strong>H</strong>ypercholesterolemia,&nbsp;<strong>H</strong>ypertrophic obstructive cardiomyopathy,&nbsp; <strong>H</strong>untington&rsquo;s disease</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">\n<div class=\"p1\"><span><strong>A</strong>: <strong>A</strong>taxia-telangiectasia,&nbsp;<strong>A</strong>lbinism, <strong>A</strong>lkaptonuria,&nbsp;</span></div>\n</div>\n<div class=\"p1\"><span><strong>A</strong>utosomal-recessive polycystic kidney disease</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>E</strong>: <strong>E</strong>hler-Danlos syndrome</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>B</strong>: <strong>B</strong>lood disorders like&nbsp;<strong>b</strong>eta-thalassemia and sickle-cell anemia</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>A</strong>: <strong>A</strong>chondroplasia</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">\n<div class=\"p1\"><span><strong>C</strong>: <strong>C</strong>ystic fibrosis,&nbsp;</span></div>\n</div>\n<div class=\"p1\"><span><strong>C</strong>ongenital adrenal hyperplasia</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>V</strong>: <strong>V</strong>on Willebrand disease, Von Hippel Lindau disease</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>D</strong>: Sensorineural <strong>d</strong>eafness</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>D</strong>: <strong>D</strong>ystrophia myotonica</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">\n<div class=\"p1\"><span><strong>E</strong>: <strong>E</strong>mphysema&nbsp;</span></div>\n</div>\n<div class=\"p1\"><span>(alpha1- antitrypsin deficiency)</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>O</strong>: <strong>O</strong>steogenesis imperfecta,&nbsp;<strong>O</strong>tosclerosis (variable)</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>F</strong>: <strong>F</strong>riedrich ataxia</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>M</strong>: <strong>M</strong>arfans syndrome, Multiple endocrine neoplasias (MEN)</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>G</strong>: <strong>G</strong>aucher&rsquo;s disease, <strong>G</strong>alactosemia, glycogen storage diseases</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>I</strong>: <strong>I</strong>ntermittent porphyria</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>H</strong>: <strong>H</strong>omocystinuria, <strong>H</strong>emochromatosis</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>N</strong>: <strong>N</strong>eurofibromatosis 1 and 2</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>I</strong>: <strong>I</strong>nborn errors of metabolism- Phenylketonuria, lysosomal storage diseases</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\"><span><strong>A</strong>: <strong>A</strong>utosomal-dominant polycystic kidney disease</span></td>\n<td class=\"td1\" valign=\"top\">Other conditions: Wilson's disease, sickle cell anemia, thalassemias, spinal muscular atrophy, Kartagener syndrome,&nbsp;</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\"><span><strong>N</strong>: <strong>N</strong>oonan's syndrome</span></td>\n<td class=\"td1\" valign=\"top\">Mucopolysaccharidoses (except Hunter syndrome)</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\"><span><strong>T</strong>: <strong>T</strong>uberous sclerosis</span></td>\n<td class=\"td1\" valign=\"top\">Sphingolipidoses (except Fabry disease)</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\"><span>Other conditions:<strong>&nbsp;</strong>Familial adenomatous polyposis, Hereditary hemorrhagic telangiectasia, Li-Fraumeni syndrome, Pseudohypoparathyroidism</span></td>\n<td class=\"td1\" valign=\"top\">&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><table class=\"t1\">\n<tbody>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>X-linked recessive</strong></span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>X-linked dominant</strong></span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>Lady Hardinge College Girls Don&rsquo;t Care About Foolish Words</strong></span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>Red Rose </strong>for<strong> All Children</strong></span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">\n<div class=\"p1\"><span>(<strong>L</strong>ady) <strong>L</strong>esch&ndash;Nyhan syndrome,&nbsp;<strong>L</strong>owe syndrome</span></div>\n</div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>R</strong>ed) <strong>R</strong>ett&rsquo;s syndrome</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>H</strong>ardinge) <strong>H</strong>unter's syndrome, <strong>H</strong>emophilia A and B</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>R</strong>ose) <strong>R</strong>ickets</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>C</strong>ollege) <strong>C</strong>hronic granulomatous disease</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div><span>(<strong>A</strong>ll) <strong>A</strong>lport syndrome&nbsp;(common inheritance pattern)</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>G</strong>irls) <strong>G</strong>-6-PD deficiency</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>C</strong>hildren) Type X <strong>C</strong>harcot&ndash;Marie&ndash;Tooth disease</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>D</strong>on&rsquo;t) <strong>D</strong>uchenne muscular dystrophy, <strong>D</strong>iabetes insipidus</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">&nbsp;</div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>C</strong>are) <strong>C</strong>olor blindness</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p2\">&nbsp;</div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">\n<div class=\"p1\"><span>(<strong>A</strong>bout) <strong>A</strong>gammaglobulinemia,&nbsp;<strong>A</strong>lport syndrome, Ocular&nbsp;<strong>a</strong>lbinism</span></div>\n</div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p2\">&nbsp;</div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(Foolish)&nbsp;<strong>F</strong>abry disease</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">&nbsp;</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>W</strong>ords) <strong>W</strong>iskott&ndash;Aldrich syndrome</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">&nbsp;</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">\n<div class=\"p1\"><span>Other conditions: Menke's disease,&nbsp;</span>Ornithine transcarbamylase deficiency</div>\n</div>\n</td>\n<td class=\"td1\" valign=\"top\">&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><span>&nbsp;</span></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG0999",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following conditions will not show gastric acid secretion after the injection of pentagastrin?",
      "choices": [
        {
          "id": 1,
          "text": "Normal healthy individual"
        },
        {
          "id": 2,
          "text": "Gastrinoma"
        },
        {
          "id": 3,
          "text": "Pernicious anemia"
        },
        {
          "id": 4,
          "text": "Duodenal ulcer"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The correct answer is <strong>pernicious anemia </strong>that can have atrophic gastritis.</p>\n<p><strong>Pentagastrin</strong> is a synthetic hormone that stimulates the release of <strong>gastrin from the G cells</strong> of the stomach. <strong>Gastrin</strong> stimulates gastric acid secretion. In pernicious anemia there are:</p>\n<ul>\n<li aria-level=\"1\"><strong>Antibodies to parietal cells and intrinsic factor</strong></li>\n<li aria-level=\"1\">Reduced serum pepsinogen I concentration</li>\n<li aria-level=\"1\"><strong>Hypergastrinemia</strong></li>\n<li aria-level=\"1\">Endocrine cell hyperplasia → Carcinoid tumors</li>\n<li aria-level=\"1\">Vitamin B12 deficiency (pernicious anemia)</li>\n<li aria-level=\"1\"><strong>Defective gastric acid secretion (achlorhydria)</strong></li>\n</ul>\n<p>After the injection of pentagastrin, patients with atrophic gastritis/pernicious anemia will typically show a<strong> weak or absent gastric acid response due to destruction of the parietal cells.</strong></p>\n<p>Other options:</p>\n<p>Normal healthy individual: A normal healthy individual will show gastric H+ secretion after the injection of pentagastrin. This is because gastrin is a potent stimulator of gastric acid secretion.</p>\n<p>Gastrinoma: A gastrinoma is a tumor of the G cells of the stomach. Gastrinomas produce excess gastrin, which leads to <strong>hypergastrinemia and increased gastric acid secretion</strong>. Therefore, patients with gastrinomas will show a <strong>vigorous gastric acid response</strong> after the injection of pentagastrin.</p>\n<p>Duodenal ulcer: Duodenal ulcers are caused by an imbalance between gastric acid secretion and mucosal defense mechanisms. Duodenal ulcer patients typically have <strong>normal or increased gastric acid secretion</strong>. Therefore, duodenal ulcer patients will typically show a<strong> vigorous gastric acid response</strong> after the injection of pentagastrin.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG1033",
      "difficulty": "medium"
    },
    {
      "text": "You have a 55-year-old male patient with a history of infective endocarditis presents with high-grade fever, new-onset murmurs, and splinter hemorrhages. What is the correct way to collect blood culture samples?",
      "choices": [
        {
          "id": 1,
          "text": "3 sets of culture samples, 2 from the peripheral lines and 1 from the affected valve with a gap of 30 minutes between the collection of each"
        },
        {
          "id": 2,
          "text": "2 samples, 1 from the periphery and 1 from atrium, with a gap of 30 minutes between the collection of each"
        },
        {
          "id": 3,
          "text": "1 from the periphery"
        },
        {
          "id": 4,
          "text": "1 from the blood and 1 from the urinary catheter"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p data-sourcepos=\"11:1-11:147\">Correct way to collect sample is <strong>3 sets of culture samples, 2 </strong>from the<strong> peripheral lines </strong>and<strong> 1 </strong>from the <strong>affected valve </strong>with<strong> a gap of 30 minutes </strong>between the collection of each</p>\n<p data-sourcepos=\"13:1-13:377\">The American Heart Association recommends collecting three sets of blood culture samples for patients with suspected infective endocarditis. One set should be collected from the affected valve, if possible. The other two sets should be collected from peripheral veins. There should be a gap of at least 30 minutes between the collection of each set.</p>\n<p data-sourcepos=\"25:1-25:105\"> </p><hr><h3>Related Pearl: Modified Duke's criteria for diagnosis of infective endocarditis</h3><div class=\"page\" title=\"Page 2415\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Diagnosis of Infective endocarditis is by Duke's Criteria, which requires either:</p>\n</div>\n</div>\n</div>\n</div>\n<ol>\n<li>Pathologic criteria</li>\n<li>Clinical criteria</li>\n</ol>\n<p>If clinical criteria are used, definitive endocarditis is defined by the presence of&nbsp;<strong>2 major </strong>or&nbsp;<strong>1 major + 3 minor </strong>or&nbsp;<strong>5 minor criteria.</strong></p>\n<p>The presence of single pathological criteria is definitive of infective endocarditis.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/186ed21749ed4d3ab7e43344abb39a78x1200x2770.JPEG\" alt=\"Pearl Image\"><p>Note:&nbsp;The diagnosis of endocarditis is rejected if an alternative diagnosis is established either when:</p>\n<ul class=\"p-rich_text_list p-rich_text_list__bullet\" data-stringify-type=\"unordered-list\" data-indent=\"0\" data-border=\"0\">\n<li data-stringify-indent=\"0\" data-stringify-border=\"0\">Symptoms resolve and do not recur with &lt;4 days of antibiotic therapy OR</li>\n<li data-stringify-indent=\"0\" data-stringify-border=\"0\">If surgery or autopsy yields no pathologic or macroscopic evidence of endocarditis in &lt;4 days of antimicrobial therapy.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG1038",
      "difficulty": "easy"
    },
    {
      "text": "A 26-year-old patient presents with a history of headache, fever, and neck stiffness for several days. Cerebrospinal fluid (CSF) analysis reveals the following parameters: protein 62, glucose 20 mg/dl (plasma glucose 140 mg/dl), and white blood cells composed of lymphocytes. What is the most likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Coxsackievirus meningitis"
        },
        {
          "id": 2,
          "text": "HSV1 meningitis"
        },
        {
          "id": 3,
          "text": "Bacterial meningitis"
        },
        {
          "id": 4,
          "text": "Tubercular meningitis"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The <strong>lymphocytic predominance</strong> and <strong>low CSF glucose</strong> points to a diagnosis of<strong> tubercular meningitis</strong>. </p>\n<p><strong>Note: CSF glucose/Serum glucose &lt; 0.4</strong> -&gt; <strong>Hypoglycorrhachia</strong>; Secondary to glycolysis by bacteria or leukocytes, and/or by altered glucose transport.</p>\n<p>Tuberculous meningitis caused by <em><strong>Mycobacterium tuberculosis</strong></em> is caused by the formation of <strong>tubercles</strong> in the brain parenchyma. This happens during the hematogenous spread of the bacilli during primary infection. It can also be due to the rupture of a subependymal tubercle into the subarachnoid space.</p>\n<p>Tuberculous meningitis presents as a <strong>subacute infection</strong> and has a longer course than bacterial meningitis. <strong>Ocular nerve palsy</strong> is a common association as there is marked meningeal involvement at the base of the brain. The patient can also develop hydrocephalus.</p>\n<p>The CSF sample shows a pellicle or <strong>cobweb-like clots</strong>. <strong>Acid-fast bacilli</strong> can be best isolated from these. There is usually <strong>lymphocytic leukocytosis</strong>, <strong>low glucose </strong>concentration, and <strong>elevated proteins</strong>. CSF culture remains the gold standard for diagnosis. </p>\n<p>The clinical triad of <strong>fever</strong>, <strong>headache</strong>, and<strong> nuchal rigidity</strong> is common to all types of meningitis. Nuchal rigidity is the resistance of the neck to passive flexion and is pathognomonic of meningeal irritation. <strong>Kernig's</strong> and <strong>Brudzinski's</strong> signs are other features of meningeal irritation. <strong>Raised intracranial pressure</strong> (ICP) is a complication that presents as<strong> papilledema</strong>, disorientation, or dilated poorly reactive pupils.</p>\n<p><strong>Important features of TB meningitis:</strong></p>\n<ul>\n<li>Common between 6 months and 4 years of age</li>\n<li>Usually spread by <strong>hematogenous</strong> route</li>\n<li>Gelatinous exudate infiltrates corticomeningeal blood vessels leading to hydrocephalus.</li>\n<li>Three stages\n<ul>\n<li><strong>Prodromal</strong> stage</li>\n<li>stage of <strong>meningitis</strong></li>\n<li>stage of <strong>coma</strong></li>\n</ul>\n</li>\n<li>CSF study shows reduced sugar level, increased protein level, and <strong>lymphocytosis.</strong></li>\n<li>Treatment includes <strong>antitubercular drugs</strong> for 12 months and <strong>corticosteroids</strong> (to reduce neurologic sequelae).</li>\n</ul>\n<p data-sourcepos=\"14:3-14:322\">Other options:</p>\n<p data-sourcepos=\"14:3-14:322\"><strong>Coxsackie</strong> meningitis is a viral meningitis. (aseptic meningitis) The CSF findings in Coxsackie meningitis are typically <strong>normal-elevated protein</strong> and <strong>lymphocytic pleocytosis</strong>. The <strong>glucose</strong> level in the CSF is usually <strong>normal. </strong></p>\n<p data-sourcepos=\"14:3-14:322\">The CSF findings in <strong>HSV encephalitis</strong> are typically <strong>normal-elevated protein</strong> and <strong>lymphocytic pleocytosis, and RBCs </strong>due to hemorrhagic necrosis of the temporal lobe. <strong>CSF Glucose</strong> levels would be <strong>normal.</strong></p>\n<p data-sourcepos=\"18:3-18:6\">The CSF findings in <strong>bacterial meningitis</strong> are typically <strong>elevated protein, neutrophilic pleocytosis </strong>and <strong>low glucose</strong> level.</p>\n<p data-sourcepos=\"20:3-20:231\"> </p><hr><h3>Related Pearl: CSF findings in meningitis</h3><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Glucose&nbsp;</strong><br /><strong>(mg/dL)</strong></td>\n<td><strong>Protein</strong><br /><strong>(mg/dL)</strong></td>\n<td><strong>WBC (per&nbsp;&mu;L)</strong></td>\n</tr>\n<tr>\n<td><strong>Normal</strong></td>\n<td>40-85</td>\n<td>15-45</td>\n<td>\n<p>&lt;5</p>\n<p>60-70% lymphocytes, &le;30% monocytes / macrophages</p>\n</td>\n</tr>\n<tr>\n<td><strong>Bacterial</strong></td>\n<td>&lt;40</td>\n<td>&gt;100</td>\n<td>\n<p>&gt;1000</p>\n<p>&uarr;&uarr;PMNs (&ge;80%)</p>\n</td>\n</tr>\n<tr>\n<td><strong>Viral</strong></td>\n<td>Normal</td>\n<td>20-80</td>\n<td>\n<p>25-500</p>\n<p>Predominantly lymphocytes</p>\n</td>\n</tr>\n<tr>\n<td><strong>Tuberculous</strong></td>\n<td>&lt;50 <br />in 75% cases</td>\n<td>100-200</td>\n<td>\n<p>25-100</p>\n<p>Predominantly lymphocytes</p>\n</td>\n</tr>\n<tr>\n<td><strong>Fungal</strong></td>\n<td>&darr; to normal</td>\n<td>150-300</td>\n<td>\n<p>40-600</p>\n<p>Lymphocytes or PMNs, depending on specific organism</p>\n</td>\n</tr>\n<tr>\n<td><strong>Parasitic</strong></td>\n<td>Normal</td>\n<td>50-200&nbsp;</td>\n<td>\n<p>150-2000</p>\n<p>&uarr;&uarr; Eosinophils (&ge;50%)</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG1050",
      "difficulty": "medium"
    },
    {
      "text": "The protease of V.cholera disrupts the extracellular part of which of the following proteins?",
      "choices": [
        {
          "id": 1,
          "text": "Occludin"
        },
        {
          "id": 2,
          "text": "Integrin"
        },
        {
          "id": 3,
          "text": "Cadherin"
        },
        {
          "id": 4,
          "text": "Claudin"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The<strong> protease</strong> of Vibrio cholera disrupts the extracellular part of<strong> occludin.</strong></p>\n<p>Occludin is a <strong>transmembrane protein</strong> that is found in tight junctions; prevents the <strong>leakage of fluids and molecules across the epithelium</strong>. The protease of V. cholera cleaves occludin, which disrupts the tight junctions and allows for the <strong>leakage of fluids and electrolytes into the intestinal lumen.</strong> This leads to the<strong> profuse diarrhea</strong> that is characteristic of cholera.</p>\n<p>Vibrio cholerae in addition to the cholera toxin (CT) produces some additional toxins such as, </p>\n<ul>\n<li><strong>Zonula occludens toxin</strong>, which alters the intestinal permeability by acting on <strong>intestinal epithelial cell tight junctions</strong> (which are also called <strong>zonula occludens</strong>)</li>\n<li><strong>Accessory cholera enterotoxin</strong>.</li>\n</ul>\n<p><strong>Zonula occludens:</strong></p>\n<ul>\n<li>Also known as <strong>tight junctions</strong></li>\n<li>Characteristically surround the apical margins of the cells in epithelia such as the intestinal mucosa, the walls of the renal tubules, and the choroid plexus.</li>\n<li>Also important to the endothelial barrier function and endothelium-dependent vasodilation.</li>\n<li>Made up of <strong>ridges</strong>- half from one cell and a half from another cell- which adhere so strongly that there is no space between the cells.</li>\n<li>Three families of transmembrane proteins are involved:</li>\n</ul>\n<p>Other options:</p>\n<p>Integrin: transmembrane proteins that mediate cell adhesion to the extracellular matrix. They are not involved in tight junctions.</p>\n<p>Cadherin: transmembrane proteins that mediate cell adhesion to other cells. They are not involved in tight junctions.</p>\n<p>Claudins are transmembrane proteins that are also found in tight junctions. However, the protease of V. cholera does not cleave claudins.</p>\n<table>\n<tbody>\n<tr>\n<td>Protein</td>\n<td>Function</td>\n<td>Disease association</td>\n</tr>\n<tr>\n<td>Integrin</td>\n<td>Cell adhesion and migration</td>\n<td>Leukocyte adhesion deficiency, Glanzmann thrombasthenia, muscular dystrophies</td>\n</tr>\n<tr>\n<td>Cadherin</td>\n<td>Cell-cell adhesion</td>\n<td>E-cadherin mutations: gastric cancer </td>\n</tr>\n<tr>\n<td>Occludin</td>\n<td>Tight junction protein</td>\n<td>Inflammatory bowel disease, celiac disease, Vibrio cholerae infection</td>\n</tr>\n<tr>\n<td>Claudin</td>\n<td>Tight junction protein</td>\n<td>Claudin-1 mutations: familial hypomagnesemia with hypercalciuria, nephrocalcinosis syndrome</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG1032",
      "difficulty": "medium"
    }
  ]
}